Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	mitotic DNA damage checkpoint signaling	CRADD CCND1 RINT1 TOPBP1 MUS81 C10orf90 RFWD3 CDK5RAP3 ATM	3.62e-07	91	209	9	GO:0044773
GeneOntologyBiologicalProcess	mitotic DNA integrity checkpoint signaling	CRADD CCND1 RINT1 TOPBP1 MUS81 C10orf90 RFWD3 CDK5RAP3 ATM	5.24e-07	95	209	9	GO:0044774
GeneOntologyBiologicalProcess	DNA damage checkpoint signaling	CRADD CCND1 RINT1 TOPBP1 MUS81 C10orf90 RFWD3 CDK5RAP3 ATM	1.04e-05	136	209	9	GO:0000077
GeneOntologyBiologicalProcess	DNA integrity checkpoint signaling	CRADD CCND1 RINT1 TOPBP1 MUS81 C10orf90 RFWD3 CDK5RAP3 ATM	1.75e-05	145	209	9	GO:0031570
GeneOntologyBiologicalProcess	negative regulation of mitotic cell cycle	CRADD CCND1 RINT1 NLE1 RBL2 TOPBP1 MUS81 C10orf90 RFWD3 CDK5RAP3 RBM46 ATM	3.26e-05	282	209	12	GO:0045930
GeneOntologyBiologicalProcess	DNA damage response	CRADD SUPT20HL2 CCND1 TRIP12 EMSY FANCA RINT1 NYNRIN RAD54B REV1 SUPT20H FAAP24 CHAF1A TOPBP1 MUS81 C10orf90 PALB2 RFWD3 RIF1 CDK5RAP3 KASH5 NEIL3 ATM NFAT5	4.25e-05	959	209	24	GO:0006974
GeneOntologyBiologicalProcess	mitotic cell cycle checkpoint signaling	CRADD CCND1 RINT1 TOPBP1 MUS81 C10orf90 RFWD3 CDK5RAP3 ATM	4.41e-05	163	209	9	GO:0007093
GeneOntologyBiologicalProcess	mitotic G2 DNA damage checkpoint signaling	RINT1 TOPBP1 C10orf90 CDK5RAP3 ATM	5.02e-05	40	209	5	GO:0007095
GeneOntologyBiologicalProcess	cell-cell adhesion	IRAK1 ITGA6 SLITRK1 SLIT2 PKP1 IGSF9 VCL CARMIL2 ANK3 DSC3 PCDHGB7 PCDHGB2 KIF26B TMIGD2 AMBRA1 GPAM THBS1 TLN1 PCDHGB4 LRP6 LRP5 NFAT5 CDH4 PALLD CDH15	9.76e-05	1077	209	25	GO:0098609
GeneOntologyBiologicalProcess	DNA repair	SUPT20HL2 TRIP12 EMSY FANCA NYNRIN RAD54B REV1 SUPT20H FAAP24 CHAF1A TOPBP1 MUS81 PALB2 RFWD3 RIF1 KASH5 NEIL3 ATM	1.13e-04	648	209	18	GO:0006281
GeneOntologyCellularComponent	adherens junction	AHI1 ARHGAP24 ITGA6 SHROOM4 PKP1 VCL TLN1 TNK2 CDH4 CDH15	5.92e-05	212	210	10	GO:0005912
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	ILF2 IRAK1 XPO5 SEC24B SEC16A ABCD3 PRRC2A VCL KPNB1 CAD ANK3 DSC3 TCOF1 DTNA ARHGEF12 MYO1B MICALL1 CDK5RAP3 MTHFD1 TLN1 EIF4G1 LRP6 CNOT1 PALLD	1.85e-11	708	215	24	39231216
Pubmed	Human transcription factor protein interaction networks.	SP1 NR2C1 KLF8 HIVEP1 ILF2 VEZF1 IRAK1 SRCAP LARP4 EMSY SMG7 ATXN1 SEC24B SEC16A ABCD3 PRRC2A VCL CAD SUPT20H ARID3A SCAF8 DTNA POU2F1 MYO1B ATXN1L RFX5 YEATS2 RIF1 KMT2D TTC31 EIF4G1 LRP6 CNOT1	7.32e-11	1429	215	33	35140242
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	SP1 HIVEP1 DAB2 TRIP12 EMSY C2CD5 CACTIN SEC16A PRRC2A CLASP1 TCOF1 SCAF8 CHAF1A POU2F1 VIRMA PALB2 PHC2 MICALL1 YEATS2 RIF1 KMT2D EIF4G1 RNF20 ATM	1.14e-10	774	215	24	15302935
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TRPM4 TRIO IRAK1 SRCAP ZNF236 AHDC1 TPCN1 FANCA SEC16A KBTBD11 MTMR3 NLE1 ARID3A SZT2 MUS81 AMBRA1 PHC2 MICALL1 CCDC142 MST1R KMT2D TLN1 CSPG4 EIF4G1 LRP5 TNK2 EVI5L	1.39e-09	1105	215	27	35748872
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	SP1 SF3B4 ILF2 VEZF1 SRCAP TRIP12 AHDC1 EMSY FANCA CACTIN TASOR KPNB1 SUPT20H TCOF1 CTDSPL2 FAAP24 CHAF1A GPATCH1 GOSR1 TOPBP1 MUS81 RFX5 PALB2 RFWD3 PHC2 YEATS2 RIF1 KMT2D RNF20	2.30e-09	1294	215	29	30804502
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	TRPM4 VEZF1 AHDC1 EMSY SEC24B ABCD3 TASOR PRRC2A CAD GNL3L SUPT20H TENT4B TBC1D30 CLASP1 SCAF8 CHAF1A GOSR1 TOPBP1 ARHGEF12 INTS8 VIRMA RBM23 PHC2 LSR HABP4 RIF1 CDK5RAP3 MTHFD1 TLN1 EIF4G1	1.51e-08	1497	215	30	31527615
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	NR2C1 ABCF3 NEDD1 LARP4 AHDC1 EMSY RINT1 SEC24B SEC16A SUPT20H ARID3A YEATS2 TLN1 EIF4G1 RNF20 PALLD	2.11e-08	444	215	16	34795231
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	NR2C1 HIVEP1 ILF2 VEZF1 NEDD1 AHDC1 EMSY XPO5 PRRC2A KPNB1 CAD ARID3A CLASP1 MAT2B POU2F1 LCP1 ATXN1L RFX5 PALB2 YEATS2 KMT2D MTHFD1 TLN1 CNOT1 ZNF292	2.59e-08	1103	215	25	34189442
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	ILF2 LARP4 TRIP12 XPO5 SEC16A NLE1 PRRC2A VCL KPNB1 CAD TCOF1 MYO1B LCP1 VIRMA RIF1 TLN1 EIF4G1 ATM CNOT1	3.00e-08	653	215	19	22586326
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	TRPM4 KLF8 POU6F2 CRADD TRIO CCND1 ZNF236 NEDD1 LARP4 AHDC1 SH3YL1 PLEKHH1 SMG7 ATXN1 IGSF9 GNL3L ANK3 SCAF8 DTNA INTS8 PLBD2 RANBP17 YEATS2 LRP5 TNK2 NFAT5 CNOT1 CDH15 EVI5L	4.97e-08	1489	215	29	28611215
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	NR2C1 HIVEP1 VEZF1 SRCAP TRIP12 ZBTB24 EMSY CACTIN RAD54B GNL3L ARID3A CTDSPL2 CHAF1A TOPBP1 POU2F1 RFX5 RIF1 ZNF292	5.42e-08	608	215	18	36089195
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	IRAK1 SRCAP EMSY SMG7 SEC24B SEC16A PRRC2A VCL KPNB1 CAD ANK3 TCOF1 YEATS2 KMT2D TLN1 CNOT1 PALLD	6.80e-08	549	215	17	38280479
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	VEZF1 SPEF2 LPCAT4 GATB SRCAP NEB TRIP12 RINT1 NLE1 TASOR KPNB1 PTBP3 PCDHGB7 PCDHGB2 CTDSPL2 ZSWIM5 DTNA CHAF1A MYO1B SPG11 LCP1 PALB2 RGS14 CSPG4 EIF4G1 PCDHGB4 ATM ZNF292	9.22e-08	1442	215	28	35575683
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	NR2C1 IRAK1 SRCAP NEDD1 EMSY SMG7 SEC24B SEC16A ABCD3 TASOR PRRC2A VCL KPNB1 GNL3L TCOF1 GPATCH1 MYO1B YEATS2 RIF1 MTHFD1 TLN1 PALLD	9.74e-08	934	215	22	33916271
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	NEB TRIP12 SLITRK1 ADGRF3 GNL3L SUPT20H ANK3 CLASP1 SPG11 LCP1 VPS13D MTHFD1 RBM46 ATM CNOT1 ZNF292	9.91e-08	497	215	16	36774506
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	SRCAP TRIP12 ZBTB24 SEC16A GNL3L SUPT20H CHAF1A TOPBP1 MUS81 LCP1 RFX5 PALB2 PHC2 LSR TLN1 RNF20 DZIP3 CNOT1	1.30e-07	645	215	18	25281560
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	SF3B4 TRIO ITGA6 CACTIN RINT1 SMG7 CASKIN2 SEC24B SEC16A MTMR3 ABCD3 PRRC2A KPNB1 CAD ANK3 DSC3 CTDSPL2 DTNA MYO1B RIF1 KMT2D LRP6 CNOT1	1.75e-07	1049	215	23	27880917
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	SP1 SF3B4 ILF2 VEZF1 ZNF236 NEDD1 EMSY C2CD5 UBE4A SMG7 SEC16A CAD SUPT20H SZT2 RBL2 CHAF1A POU2F1 SPG11 C10orf90 VIRMA HABP4 CDK5RAP3 EIF4G1 RNF20 CNOT1 ZNF292	2.33e-07	1327	215	26	32694731
Pubmed	Adenovirus preterminal protein binds to the CAD enzyme at active sites of viral DNA replication on the nuclear matrix.	SP1 CAD POU2F1	2.33e-07	3	215	3	9525610
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	HIVEP1 ILF2 TRIO UBE4A XPO5 ABCD3 PKP1 VCL KPNB1 DNHD1 CAD GNL3L TENT4B TCOF1 MAT2B CHAF1A ZNF329 THUMPD3 MYO1B RIF1 CLCA2 MTHFD1 TLN1 EIF4G1 RNF20 ATM CNOT1	2.59e-07	1425	215	27	30948266
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	FRMPD4 PLEKHH1 XPO5 SEC16A MTMR3 CLASP1 ZSWIM5 SCAF8 ARHGEF12 VIRMA YEATS2 TLN1 DZIP3 NFAT5	2.89e-07	407	215	14	12693553
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	TRIO TRIP12 XPO5 SEC16A PRRC2A CAD MYO1B THBS1 EIF4G1 CNOT1	5.86e-07	202	215	10	33005030
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	C2CD5 SLIT2 ABCD3 LRP12 CAD RNF31 DTNA GPATCH1 BTBD10 MYO1B TRIM3 ATM	6.71e-07	313	215	12	38270169
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	ILF2 ABCF3 SRCAP LARP4 TRIP12 SEC24B SEC16A ABCD3 PKP1 NLE1 VCL KPNB1 CAD GNL3L RNF31 DSC3 THUMPD3 AMBRA1 MYO1B RIF1 MTHFD1 TLN1 EIF4G1 RNF20 PALLD	1.17e-06	1353	215	25	29467282
Pubmed	Polymorphic variants in hereditary pancreatic cancer genes are not associated with pancreatic cancer risk.	FANCA RAD54B TOPBP1 PALB2 ATM	1.28e-06	31	215	5	19690177
Pubmed	The Rb-related p130 protein controls telomere lengthening through an interaction with a Rad50-interacting protein, RINT-1.	CCND1 RINT1 RBL2 LBX1	1.35e-06	14	215	4	16600870
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	AHI1 HIVEP1 DAB2 ZNF236 LARP4 EMSY SLIT2 CASKIN2 PRRC2A TBCEL CTDSPL2 FAAP24 GOSR1 BTBD10 THUMPD3 RFX5 RIF1 TLN1 EIF4G1 ALG13	1.44e-06	925	215	20	28986522
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	NR2C1 SF3B4 TRIO NCKAP5 TRIP12 SH3YL1 PLEKHH1 UBE4A MTMR3 STAMBPL1 PRRC2A KPNB1 SUPT20H ANK3 TCOF1 RBL2 ZNF329 INTS8 RFX5 THBS1 EIF4G1 ZNF76 ATM ZNF292	1.62e-06	1285	215	24	35914814
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	SF3B4 ILF2 VEZF1 LPCAT4 ITGA6 ZNF518A UBE4A RINT1 XPO5 ABCD3 KPNB1 TENT4B CLASP1 TCOF1 ZNF329 ZNF407 INTS8 VIRMA LSR RIF1 CSPG4 EIF4G1 CNOT1	1.84e-06	1203	215	23	29180619
Pubmed	Role and Regulation of p65/β-Catenin Association During Liver Injury and Regeneration: A "Complex" Relationship.	CCND1 LRP6 LRP5	2.31e-06	5	215	3	28474571
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	SMG7 ATXN1 SEC24B SEC16A SCAF8 RFX5 YEATS2 KMT2D PALLD	2.39e-06	184	215	9	32908313
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	PDE4B ARHGAP24 ILF2 CTTNBP2 TRIO EMSY SEC16A PRRC2A KPNB1 CAD ANK3 CLASP1 TCOF1 ARHGEF12 VIRMA TRIM3 EIF4G1 DZIP3 CNOT1 LRRC15	2.64e-06	963	215	20	28671696
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	ABCF3 IRAK1 ITGA6 CASKIN2 SEC24B VCL ANK3 DSC3 VASN ARHGEF12 MYO1B MICALL1 LSR TLN1 EIF4G1	2.76e-06	565	215	15	25468996
Pubmed	Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.	ILF2 PLEKHH1 SEC16A ABCD3 VCL KPNB1 ANK3 DSC3 LCP1 ATXN1L CNOT1	3.44e-06	304	215	11	32235678
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	SF3B4 SRCAP CACTIN VCL KPNB1 ARID3A TCOF1 MYO1B LCP1 YEATS2 RIF1 MTHFD1 TLN1 RNF20	3.73e-06	506	215	14	30890647
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	VEZF1 PRRC2A PTBP3 CAD TOPBP1 LCP1 VIRMA PHC2 RIF1 TLN1 EIF4G1 ATM	3.80e-06	370	215	12	22922362
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	SF3B4 ILF2 VEZF1 LARP4 TRIP12 CACTIN SEC16A PIPSL PRRC2A PTBP3 COL11A1 GNL3L CLASP1 TCOF1 MYO1B VIRMA RBM23 TRIM3 PHC2 HABP4 RIF1 TLN1 EIF4G1 CNOT1	4.89e-06	1371	215	24	36244648
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	PRRC2A CAD TCOF1 GPATCH1 VIRMA RFWD3 EIF4G1 LRP6 CNOT1	5.13e-06	202	215	9	24639526
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	HIVEP1 DAB2 AHDC1 RINT1 ATXN1 NYNRIN PRRC2A CCHCR1 SUPT20H RNF31 DTNA ATXN1L PHC2 DZIP3 ALG13	6.66e-06	608	215	15	16713569
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	LPCAT4 IRAK1 SRCAP C2CD5 ZNF518A SLIT2 CACTIN SMG7 ATXN1 SEC16A GNL3L SUPT20H RNF31 TCOF1 CHAF1A AMBRA1 YEATS2 LBX1 CDH15 EVI5L ALG13	6.73e-06	1116	215	21	31753913
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	TRIO DAB2 SEC16A VCL CLASP1 KIF26B ARHGEF12 VPS13D PALLD	6.76e-06	209	215	9	36779422
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	SP1 DAB2 SRCAP XPO5 CHAF1A RIF1 MTHFD1 TLN1 EIF4G1 RNF20 PALLD	7.92e-06	332	215	11	32786267
Pubmed	Tagging genes with cassette-exchange sites.	KLF8 TRIP12 RINT1 XPO5 SCAF8 ARHGEF12 RANBP17 LSR RIF1 EIF4G1 ZNF292	8.62e-06	335	215	11	15741177
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	SF3B4 LARP4 SEC24B SEC16A PRRC2A KPNB1 CAD DSC3 MYO1B EIF4G1	8.93e-06	274	215	10	34244482
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	ILF2 TRIO NEDD1 SLIT2 PKP1 PRRC2A SCAF8 BTBD10 ARHGEF12 HABP4 THBS1 DZIP3 NFAT5	9.36e-06	475	215	13	31040226
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	TRPM4 TCTN3 LPCAT4 IRAK1 ITGA6 NEDD1 XPO5 SEC16A LRP12 DSC3 CLASP1 GOSR1 SPG11 INTS8 LSR RIF1 CDK5RAP3 MTHFD1 ATM ALG13	1.10e-05	1061	215	20	33845483
Pubmed	Crosstalk between Nodal/activin and MAPK p38 signaling is essential for anterior-posterior axis specification.	SUPT20HL2 CER1 SUPT20H	1.28e-05	8	215	3	21802298
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	SP1 NR2C1 KLF8 HIVEP1 VEZF1 SRCAP ZNF236 ZBTB24 ATXN1 ARID3A POU2F1 RFX5 LSR RIF1 ZNF76 NFAT5 ZNF292	1.29e-05	808	215	17	20412781
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	SF3B4 ILF2 VEZF1 SRCAP TRIP12 AHDC1 ABCD3 KPNB1 PTBP3 CAD SUPT20H CLASP1 TCOF1 MYO1B INTS8 PHC2 EIF4G1 ATM CNOT1 ZNF292	1.46e-05	1082	215	20	38697112
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	PDE4B AHI1 ILF2 ABCF3 SRCAP TRIP12 ZBTB24 C2CD5 SEC16A TASOR LRRC18 CCHCR1 ANK3 ATXN1L CDK5RAP3 MTHFD1 GRAMD2B DZIP3 NFAT5 CNOT1	1.49e-05	1084	215	20	11544199
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	TCTN3 LPCAT4 ITGA6 TPCN1 FANCA RINT1 LRP12 MAT2B VASN GOSR1 PLBD2 MST1R THBS1 PRCP LOXL1 CSPG4 LRP6 LRP5 ATM DSEL PALLD	2.01e-05	1201	215	21	35696571
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	SERINC2 NEB SLIT2 PRRC2A VCL KPNB1 DNHD1 RBL2 VASN ARHGEF12 MYO1B LCP1 THBS1 VPS13D MTHFD1 PRCP TLN1 MYO15A LRRC15	2.05e-05	1016	215	19	19056867
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	SF3B4 ILF2 FRMPD4 TRIO NEB EMSY KPNB1 CAD TENT4B PALB2 PHC2 THBS1 LRRC37B	2.10e-05	513	215	13	25798074
Pubmed	Functional proteomics mapping of a human signaling pathway.	HIVEP1 DAB2 TRIP12 ZNF518A XPO5 VCL KPNB1 ANK3 ZNF329 KMT2D CSPG4 EIF4G1 LRP5 ZNF76	2.13e-05	591	215	14	15231748
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	ILF2 IRAK1 SRCAP TRIP12 SLIT2 SEC16A ABCD3 PKP1 NLE1 KPNB1 CAD TCOF1 MYO1B LSR RIF1 MTHFD1 TLN1 EIF4G1 CNOT1	2.28e-05	1024	215	19	24711643
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	GGA2 TRIO IRAK1 NEDD1 EMSY RINT1 SMG7 SEC24B VCL KPNB1 CCHCR1 GPATCH1 GOSR1 LCP1 MICALL1 TLN1 CNOT1	2.57e-05	853	215	17	28718761
Pubmed	Hypertonicity-responsive ubiquitin ligase RNF183 promotes Na, K-ATPase lysosomal degradation through ubiquitination of its β1 subunit.	UBE4A SEC24B SEC16A ABCD3 KPNB1 TCOF1 DTNA GOSR1 ARHGEF12 MICALL1 TLN1 EIF4G1	2.61e-05	449	215	12	31732153
Pubmed	Comprehensive analysis of DNA repair gene variants and risk of meningioma.	FANCA REV1 CHAF1A NEIL3 ATM	2.78e-05	57	215	5	18270339
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	TRIO ITGA6 SMG7 CASKIN2 PKP1 NLE1 COL11A1 SUPT20H CTDSPL2 KIF26B CHAF1A LSR CDK5RAP3 RNF20 NEIL3	2.86e-05	689	215	15	36543142
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SF3B4 HIVEP1 TRIO TRIP12 ATXN1 CASKIN2 SEC24B SEC16A CARMIL2 CLASP1 KIF26B VIRMA MICALL1 LSR VPS13D EIF4G1 PALLD	2.89e-05	861	215	17	36931259
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	NR2C1 SF3B4 HIVEP1 ILF2 VEZF1 TRIP12 EMSY SEC16A TASOR PRRC2A KPNB1 CHAF1A GPATCH1 TOPBP1 RFX5 YEATS2 RIF1 EIF4G1	3.03e-05	954	215	18	36373674
Pubmed	Functional genomic landscape of cancer-intrinsic evasion of killing by T cells.	GATB SUPT20HL2 SRCAP LARP4 SMG7 CAD SUPT20H RNF31 TCOF1 GOSR1 AMBRA1 ZNF407	3.10e-05	457	215	12	32968282
Pubmed	Hundreds of variants clustered in genomic loci and biological pathways affect human height.	SF3B4 CRADD NCKAP5 ZBTB24 TASOR HTR1D LOXL1 LRRC37B	3.48e-05	198	215	8	20881960
Pubmed	The transcription factors Sp1 and Oct-1 interact physically to regulate human U2 snRNA gene expression.	SP1 POU2F1	3.80e-05	2	215	2	8668525
Pubmed	Dissecting molecular differences between Wnt coreceptors LRP5 and LRP6.	LRP6 LRP5	3.80e-05	2	215	2	21887268
Pubmed	[Novel bidirectional promoter from human genome].	CCDC142 TTC31	3.80e-05	2	215	2	21790010
Pubmed	PAR1&2 driven placenta EVT invasion act via LRP5/6 as coreceptors.	LRP6 LRP5	3.80e-05	2	215	2	33136328
Pubmed	The EMSY Gene Collaborates with CCND1 in Non-Small Cell Lung Carcinogenesis.	CCND1 EMSY	3.80e-05	2	215	2	28824300
Pubmed	The activity of the vinculin binding sites in talin is influenced by the stability of the helical bundles that make up the talin rod.	VCL TLN1	3.80e-05	2	215	2	16407302
Pubmed	LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way.	LRP6 LRP5	3.80e-05	2	215	2	15084453
Pubmed	Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of polyglutamine-expanded ataxin-1 into native complexes.	ATXN1 ATXN1L	3.80e-05	2	215	2	17322884
Pubmed	TASOR epigenetic repressor cooperates with a CNOT1 RNA degradation pathway to repress HIV.	TASOR CNOT1	3.80e-05	2	215	2	35013187
Pubmed	Dystrophin-glycoprotein complex and vinculin-talin-integrin system in human adult cardiac muscle.	VCL TLN1	3.80e-05	2	215	2	19148538
Pubmed	Expression pattern of ATM and cyclin D1 in ductal carcinoma, normal adjacent and normal breast tissues of Iranian breast cancer patients.	CCND1 ATM	3.80e-05	2	215	2	21850541
Pubmed	Vinculins interaction with talin is essential for mammary epithelial differentiation.	VCL TLN1	3.80e-05	2	215	2	31804547
Pubmed	Co-deletion of Lrp5 and Lrp6 in the skeleton severely diminishes bone gain from sclerostin antibody administration.	LRP6 LRP5	3.80e-05	2	215	2	33164872
Pubmed	Genetic alterations of CCND1 and EMSY in breast cancers.	CCND1 EMSY	3.80e-05	2	215	2	18393977
Pubmed	MIER3 suppresses colorectal cancer progression by down-regulating Sp1, inhibiting epithelial-mesenchymal transition.	SP1 MIER3	3.80e-05	2	215	2	28887525
Pubmed	Maximal Expression of the Evolutionarily Conserved Slit2 Gene Promoter Requires Sp1.	SP1 SLIT2	3.80e-05	2	215	2	26456684
Pubmed	Systematic RNAi studies on the role of Sp/KLF factors in globin gene expression and erythroid differentiation.	SP1 KLF8	3.80e-05	2	215	2	17224162
Pubmed	LRP5/6 directly bind to Frizzled and prevent Frizzled-regulated tumour metastasis.	LRP6 LRP5	3.80e-05	2	215	2	25902418
Pubmed	ATM is required for rapid degradation of cyclin D1 in response to gamma-irradiation.	CCND1 ATM	3.80e-05	2	215	2	19071090
Pubmed	Sp1 phosphorylation by ATM downregulates BER and promotes cell elimination in response to persistent DNA damage.	SP1 ATM	3.80e-05	2	215	2	29294106
Pubmed	Enhanced phosphorylation of transcription factor sp1 in response to herpes simplex virus type 1 infection is dependent on the ataxia telangiectasia-mutated protein.	SP1 ATM	3.80e-05	2	215	2	17609267
Pubmed	Two distinct head-tail interfaces cooperate to suppress activation of vinculin by talin.	VCL TLN1	3.80e-05	2	215	2	15728584
Pubmed	RNA-Binding RING E3-Ligase DZIP3/hRUL138 Stabilizes Cyclin D1 to Drive Cell-Cycle and Cancer Progression.	CCND1 DZIP3	3.80e-05	2	215	2	33067265
Pubmed	The involvement of the canonical Wnt-signaling receptor LRP5 and LRP6 gene variants with ADHD and sexual dimorphism: Association study and meta-analysis.	LRP6 LRP5	3.80e-05	2	215	2	30474181
Pubmed	Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancers.	CCND1 EMSY	3.80e-05	2	215	2	19636701
Pubmed	In Adult Skeletal Muscles, the Co-Receptors of Canonical Wnt Signaling, Lrp5 and Lrp6, Determine the Distribution and Size of Fiber Types, and Structure and Function of Neuromuscular Junctions.	LRP6 LRP5	3.80e-05	2	215	2	36552732
Pubmed	Idiopathic Juvenile Osteoporosis: Clinical Experience from a Single Centre and Screening of LRP5 and LRP6 Genes.	LRP6 LRP5	3.80e-05	2	215	2	25783012
Pubmed	Gene targeting approaches in mice: assessing the roles of LRP5 and LRP6 in osteoblasts.	LRP6 LRP5	3.80e-05	2	215	2	19147944
Pubmed	Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6.	LRP6 LRP5	3.80e-05	2	215	2	15537447
Pubmed	LRP5 and LRP6 are not required for protective antigen-mediated internalization or lethality of anthrax lethal toxin.	LRP6 LRP5	3.80e-05	2	215	2	17335347
Pubmed	Structural basis for amplifying vinculin activation by talin.	VCL TLN1	3.80e-05	2	215	2	15070891
Pubmed	Regulation of RON tyrosine kinase-mediated invasion of breast cancer cells.	SP1 MST1R	3.80e-05	2	215	2	18165235
Pubmed	The Wnt co-receptor Lrp6 is required for normal mouse mammary gland development.	LRP6 LRP5	3.80e-05	2	215	2	19503830
Pubmed	Upregulated ATM gene expression and activated DNA crosslink-induced damage response checkpoint in Fanconi anemia: implications for carcinogenesis.	FANCA ATM	3.80e-05	2	215	2	18224251
Pubmed	LRP5-/6 gene polymorphisms and its association with risk of abnormal bone mass in postmenopausal women.	LRP6 LRP5	3.80e-05	2	215	2	37202775
Pubmed	Wnt receptors, bone mass, and fractures: gene-wide association analysis of LRP5 and LRP6 polymorphisms with replication.	LRP6 LRP5	3.80e-05	2	215	2	20926594
Pubmed	Common genetic variation of the low-density lipoprotein receptor-related protein 5 and 6 genes determines fracture risk in elderly white men.	LRP6 LRP5	3.80e-05	2	215	2	16355283
Interaction	BRCA1 interactions	SP1 HIVEP1 ILF2 TRIO CCND1 EMSY FANCA SMG7 SEC24B SEC16A SAGE1 VCL KPNB1 REV1 DNHD1 CAD GNL3L TCOF1 DTNA RBL2 FAAP24 CHAF1A SOX30 TOPBP1 MUS81 POU2F1 PALB2 RIF1 MTHFD1 TLN1 EIF4G1 RNF20 DZIP3 ATM CNOT1 PALLD	2.81e-08	1249	211	36	int:BRCA1
Interaction	KCNA3 interactions	ILF2 SPEF2 IRAK1 XPO5 SEC24B SEC16A ABCD3 PRRC2A VCL KPNB1 DNHD1 CAD ANK3 DSC3 TCOF1 SZT2 DTNA ARHGEF12 MYO1B MICALL1 YEATS2 CDK5RAP3 MTHFD1 TLN1 EIF4G1 LRP6 CNOT1 PALLD	1.32e-07	871	211	28	int:KCNA3
Interaction	KLF8 interactions	SP1 NR2C1 KLF8 ARHGAP24 HIVEP1 ILF2 EMSY ATXN1 SEC16A PRRC2A SUPT20H POU2F1 MICALL1 YEATS2 KMT2D EIF4G1	4.12e-07	329	211	16	int:KLF8
Interaction	TLE3 interactions	HIVEP1 VEZF1 AHDC1 EMSY CACTIN SMG7 ATXN1 SAGE1 ANK3 SCAF8 GPATCH1 MYO1B ATXN1L VIRMA KMT2D DZIP3 ALG13	4.93e-07	376	211	17	int:TLE3
Interaction	FOXL1 interactions	HIVEP1 ABCF3 UBE4A RINT1 ATXN1 ARID3A POU2F1 MYO1B ATXN1L RIF1 KMT2D EIF4G1	1.12e-06	196	211	12	int:FOXL1
Interaction	TOP3B interactions	TRPM4 TRIO IRAK1 SRCAP ZNF236 NEDD1 LARP4 AHDC1 TPCN1 FANCA SMG7 XPO5 SEC24B SEC16A KBTBD11 MTMR3 NLE1 PRRC2A CAD ARID3A SZT2 MUS81 AMBRA1 MYO1B PHC2 MICALL1 CCDC142 MST1R KMT2D TLN1 CSPG4 EIF4G1 LRP5 TNK2 CNOT1 EVI5L	1.47e-06	1470	211	36	int:TOP3B
Interaction	NUP43 interactions	NR2C1 HIVEP1 SRCAP TRIP12 AHDC1 EMSY ZNF518A CACTIN KPNB1 LRP12 GNL3L SZT2 GPATCH1 TOPBP1 VIRMA YEATS2 RIF1 KMT2D EIF4G1 CNOT1 ZNF292	2.77e-06	625	211	21	int:NUP43
Interaction	APEX1 interactions	NR2C1 AHI1 HIVEP1 DAB2 SRCAP ZNF236 LARP4 TRIP12 EMSY SLIT2 CACTIN CASKIN2 PRRC2A TBCEL GNL3L ARID3A TCOF1 CTDSPL2 FAAP24 CHAF1A GOSR1 BTBD10 THUMPD3 TOPBP1 RFX5 VIRMA RIF1 TLN1 EIF4G1 ATM ZNF292 ALG13	3.47e-06	1271	211	32	int:APEX1
Interaction	FEV interactions	NR2C1 HIVEP1 VEZF1 EMSY ATXN1 SUPT20H ARID3A POU2F1 ATXN1L RFX5 KMT2D	1.01e-05	203	211	11	int:FEV
Interaction	H2BC8 interactions	MIER3 SRCAP TRIP12 ZBTB24 CACTIN SEC16A TASOR GNL3L ARID3A CTDSPL2 CHAF1A TOPBP1 MUS81 RFX5 VIRMA PALB2 PHC2 RIF1 ZNF292	1.09e-05	576	211	19	int:H2BC8
Interaction	CAPZA2 interactions	PDE4B DAB2 ATXN1 SEC16A PKP1 STAMBPL1 CARMIL2 CLASP1 MYO1B LCP1 VIRMA MICALL1 MST1R RGS14 CNOT1 LRRC15	1.29e-05	430	211	16	int:CAPZA2
Interaction	EGR2 interactions	NR2C1 HIVEP1 AHDC1 EMSY ATXN1 SEC16A ARID3A ATXN1L KMT2D RNF20	1.33e-05	171	211	10	int:EGR2
Interaction	TP53BP1 interactions	NR2C1 POU6F2 ILF2 EMSY SLIT2 UBE4A SAGE1 KPNB1 ARID3A RBL2 CHAF1A TOPBP1 MUS81 VIRMA PALB2 RIF1 RNF20 ATM	1.37e-05	533	211	18	int:TP53BP1
Interaction	ZC3H7A interactions	LARP4 SMG7 NYNRIN PRRC2A SPG11 TTC31 TLN1 EIF4G1 DZIP3 CNOT1 ALG13	1.74e-05	215	211	11	int:ZC3H7A
Interaction	H3C3 interactions	NR2C1 HIVEP1 VEZF1 SRCAP TRIP12 ZBTB24 CACTIN RAD54B GNL3L ARID3A CTDSPL2 CHAF1A TOPBP1 POU2F1 RFX5 RIF1 ZNF292	1.94e-05	495	211	17	int:H3C3
Interaction	PCDHGB7 interactions	PCDHGB7 PCDHGB2 VIRMA	2.21e-05	6	211	3	int:PCDHGB7
Interaction	CPAP interactions	TRIO NEDD1 SMG7 SEC24B SEC16A CLASP1 GPATCH1 VIRMA CNOT1 PALLD	2.29e-05	182	211	10	int:CPAP
Interaction	POU6F2 interactions	POU6F2 HIVEP1 VEZF1 LARP4 ZBTB24 OPLAH CCHCR1 CHAF1A POU2F1	2.66e-05	148	211	9	int:POU6F2
Interaction	HIVEP1 interactions	KLF8 POU6F2 HIVEP1 VEZF1 SMG7 ATXN1 MTMR3 POU2F1 ATXN1L VIRMA	2.76e-05	186	211	10	int:HIVEP1
Interaction	NFIX interactions	NR2C1 HIVEP1 SRCAP EMSY ATXN1 VCL ARID3A POU2F1 ATXN1L RFX5 KMT2D	2.87e-05	227	211	11	int:NFIX
Interaction	SMAP2 interactions	GGA2 DAB2 LARP4 SMG7 SEC24B SEC16A STAMBPL1 PRRC2A CNOT1 ALG13	3.16e-05	189	211	10	int:SMAP2
Interaction	ELK3 interactions	NR2C1 HIVEP1 VEZF1 EMSY ATXN1 SUPT20H POU2F1 ATXN1L	3.89e-05	120	211	8	int:ELK3
Interaction	ELF1 interactions	SP1 NR2C1 KLF8 HIVEP1 SRCAP EMSY ATXN1L VIRMA	5.52e-05	126	211	8	int:ELF1
Interaction	CNOT6L interactions	SMG7 SEC16A PRRC2A VASN CHAF1A VIRMA CNOT1	5.52e-05	93	211	7	int:CNOT6L
Interaction	NPAS1 interactions	PDE4B ABCF3 IRAK1 CCND1 TRIP12 FANCA SMG7 CASKIN2 RNF31 SPG11 THBS1	5.75e-05	245	211	11	int:NPAS1
Interaction	KLF15 interactions	HIVEP1 ILF2 VEZF1 ZBTB24 EMSY SEC16A ABCD3 PRRC2A ARID3A KMT2D ZNF76 ZNF292	5.85e-05	290	211	12	int:KLF15
Interaction	RBM47 interactions	HIVEP1 LARP4 SMG7 STAMBPL1 PRRC2A PTBP3 VIRMA RBM46 ATM ALG13	6.03e-05	204	211	10	int:RBM47
Interaction	LRRC31 interactions	TRIO TRIP12 XPO5 SEC16A PRRC2A CAD MYO1B THBS1 EIF4G1 CNOT1	6.29e-05	205	211	10	int:LRRC31
Interaction	R3HDM2 interactions	SMG7 ATXN1 SEC24B SEC16A PRRC2A DZIP3 CNOT1 ALG13	6.52e-05	129	211	8	int:R3HDM2
Interaction	MORF4L2 interactions	POU6F2 SRCAP EMSY KPNB1 ARID3A PALB2 PHC2 HABP4 GRAMD2B	7.16e-05	168	211	9	int:MORF4L2
Interaction	MYB interactions	NR2C1 HIVEP1 EMSY ATXN1 ARID3A VIRMA KMT2D ZNF292	8.09e-05	133	211	8	int:MYB
Interaction	TIMELESS interactions	SP1 CACTIN TASOR TCOF1 CHAF1A MUS81 VIRMA RFWD3	9.95e-05	137	211	8	int:TIMELESS
Interaction	NCOR2 interactions	SP1 KLF8 CCND1 SMG7 ATXN1 SEC16A NLE1 POU2F1 ATXN1L VIRMA ALG13	1.12e-04	264	211	11	int:NCOR2
Interaction	POGZ interactions	SP1 KLF8 HIVEP1 VEZF1 ZBTB24 ATXN1 PIPSL CHAF1A POU2F1 MYO1B ZNF76	1.16e-04	265	211	11	int:POGZ
Interaction	SP4 interactions	SP1 HIVEP1 VEZF1 POU2F1 VIRMA	1.16e-04	46	211	5	int:SP4
Interaction	PML interactions	SP1 TCTN3 NR2C1 ABCF3 NEDD1 LARP4 AHDC1 EMSY RINT1 ATXN1 SEC24B SEC16A SUPT20H ARID3A RBL2 TOPBP1 YEATS2 MTHFD1 TLN1 EIF4G1 RNF20 ATM PALLD	1.27e-04	933	211	23	int:PML
Interaction	MYH9 interactions	SP1 ARHGAP24 HIVEP1 SPEF2 DAB2 AHDC1 ZNF518A SEC16A VCL CAD TCOF1 CTDSPL2 MYO1B VIRMA RGS14 THBS1 TLN1 EIF4G1 TNK2 PALLD	1.36e-04	754	211	20	int:MYH9
Interaction	GLDC interactions	SF3B4 ARHGAP24 LARP4 SEC24B SEC16A PRRC2A KPNB1 AMT CAD DSC3 MYO1B EIF4G1	1.53e-04	321	211	12	int:GLDC
Interaction	CTNNB1 interactions	SP1 ARHGAP24 ABCF3 CCND1 FANCA SLIT2 SEC24B SEC16A ABCD3 VCL KPNB1 CAD ANK3 DSC3 DTNA MYO1B VIRMA RGS14 KMT2D MTHFD1 TLN1 LRP6 LRP5 CDH15	1.54e-04	1009	211	24	int:CTNNB1
Interaction	EN1 interactions	HIVEP1 ATXN1 ARID3A THUMPD3 ATXN1L RIF1 KMT2D	1.60e-04	110	211	7	int:EN1
Interaction	MLLT10 interactions	POU6F2 VEZF1 SMG7 POU2F1 MTHFD1	1.91e-04	51	211	5	int:MLLT10
Interaction	FBXO22 interactions	NEB TRIP12 SLITRK1 ADGRF3 GNL3L SUPT20H ANK3 CLASP1 SPG11 LCP1 VPS13D MTHFD1 RBM46 ATM CNOT1 ZNF292	1.91e-04	540	211	16	int:FBXO22
Interaction	KLK15 interactions	ABCF3 FANCA SMG7 SEC16A MST1R THBS1 LRP6 LRP5	1.95e-04	151	211	8	int:KLK15
Interaction	DUSP16 interactions	NEDD1 SMG7 NYNRIN SEC16A CAD RNF31 SZT2 BTBD10 SPG11 VIRMA	2.07e-04	237	211	10	int:DUSP16
Interaction	CSDE1 interactions	ARHGAP24 LARP4 SMG7 ATXN1 PRRC2A VASN VIRMA RNF20 NEIL3 CNOT1 ALG13	2.12e-04	284	211	11	int:CSDE1
Interaction	VIPR2 interactions	TRPM4 RINT1 XPO5 SPG11 VIRMA RGS14 RIF1 LRRC15 EVI5L	2.13e-04	194	211	9	int:VIPR2
Interaction	BRCA2 interactions	SP1 NCKAP5 CCND1 SRCAP AHDC1 EMSY REV1 COL11A1 FAAP24 TOPBP1 VIRMA PALB2 ATM	2.16e-04	384	211	13	int:BRCA2
Interaction	KLF5 interactions	NR2C1 HIVEP1 ILF2 ATXN1 SEC16A PRRC2A ARID3A ATXN1L KMT2D	2.22e-04	195	211	9	int:KLF5
Interaction	TBXT interactions	NR2C1 HIVEP1 ATXN1 CAD ARID3A ATXN1L KMT2D	2.22e-04	116	211	7	int:TBXT
Interaction	PUM1 interactions	ILF2 LARP4 SMG7 ATXN1 SEC16A PRRC2A PTBP3 VIRMA DZIP3 CNOT1 ALG13	2.32e-04	287	211	11	int:PUM1
Interaction	BRD10 interactions	ATXN1 MUS81 VIRMA	2.32e-04	12	211	3	int:BRD10
Interaction	CHST9 interactions	LRP6 LRP5 LRRC15	2.32e-04	12	211	3	int:CHST9
Interaction	PPP2R1A interactions	KLF8 AHI1 ARHGAP24 CTTNBP2 ABCF3 CCND1 ATXN1 FOXD4 CAD GNL3L AMBRA1 INTS8 VIRMA RGS14 RIF1 VPS13D EIF4G1 ATM	2.32e-04	665	211	18	int:PPP2R1A
Interaction	SSX2IP interactions	AHI1 IRAK1 NEDD1 ZBTB24 RINT1 SMG7 SEC24B CCHCR1 GPATCH1 PHC2 CNOT1	2.39e-04	288	211	11	int:SSX2IP
Interaction	ADNP2 interactions	AHDC1 PIPSL CHAF1A VIRMA ZNF292	2.50e-04	54	211	5	int:ADNP2
Interaction	HDAC1 interactions	SP1 NR2C1 HIVEP1 MIER3 IRAK1 CCND1 EMSY ATXN1 ABCD3 TASOR KPNB1 CAD RBL2 CHAF1A POU2F1 GPAM VIRMA PALB2 YEATS2 KMT2D TLN1 RNF20 DZIP3 ZNF76 ATM	2.51e-04	1108	211	25	int:HDAC1
Interaction	RBPMS interactions	POU6F2 HIVEP1 ABCF3 VEZF1 ATXN1 NYNRIN CPEB2 PTBP3 ATXN1L RNF20 RBM46 ALG13	2.59e-04	340	211	12	int:RBPMS
Interaction	HDLBP interactions	SF3B4 ILF2 ABCF3 LARP4 ATXN1 GLRB SEC16A PRRC2A PTBP3 COL11A1 GNL3L CLASP1 TCOF1 TOPBP1 VIRMA TRIM3 PHC2 RIF1 MTHFD1 EIF4G1 NEIL3	2.64e-04	855	211	21	int:HDLBP
Interaction	ZFPL1 interactions	TRIO CASKIN2 SEC24B SEC16A ABCD3 ANK3 DSC3 DTNA GOSR1 MYO1B MICALL1 LSR VPS13D KASH5	2.82e-04	448	211	14	int:ZFPL1
Interaction	GSC interactions	HIVEP1 ATXN1 POU2F1 ATXN1L KMT2D LRRC15	3.06e-04	87	211	6	int:GSC
Interaction	VIM interactions	SP1 ARHGAP24 SPEF2 IRAK1 CCND1 NEB NEDD1 ABCA10 SH3YL1 ATXN1 PKP1 KPNB1 CAD RNF31 VIRMA HABP4 VPS13D EIF4G1 DZIP3 NEIL3	3.16e-04	804	211	20	int:VIM
Interaction	GSK3B interactions	SP1 TRIO DAB2 CCND1 TRIP12 SMG7 ATXN1 SEC16A VCL KPNB1 CAD CLASP1 KIF26B ARHGEF12 MYO1B C10orf90 VPS13D MTHFD1 EIF4G1 LRP6 PALLD	3.23e-04	868	211	21	int:GSK3B
Interaction	SIRT7 interactions	ILF2 LARP4 TRIP12 XPO5 SEC16A NLE1 PRRC2A VCL KPNB1 CAD TCOF1 MYO1B LCP1 VIRMA RIF1 TLN1 EIF4G1 ATM CNOT1	3.23e-04	744	211	19	int:SIRT7
Interaction	PAX7 interactions	NR2C1 HIVEP1 ATXN1 ARID3A POU2F1 ATXN1L KMT2D	3.34e-04	124	211	7	int:PAX7
Interaction	SORT1 interactions	GGA2 C2CD5 TENT4B TCOF1 MUS81 VIRMA PHC2 TLN1 CSPG4	3.57e-04	208	211	9	int:SORT1
Interaction	CRX interactions	SP1 NR2C1 LARP4 ATXN1 ARID3A SZT2 POU2F1 ATXN1L KMT2D ATM	3.60e-04	254	211	10	int:CRX
Interaction	PRR20B interactions	POU6F2 HIVEP1 VEZF1 ATXN1 POU2F1 RBM23	3.68e-04	90	211	6	int:PRR20B
Interaction	PRR20C interactions	POU6F2 HIVEP1 VEZF1 ATXN1 POU2F1 RBM23	3.68e-04	90	211	6	int:PRR20C
Interaction	PRR20D interactions	POU6F2 HIVEP1 VEZF1 ATXN1 POU2F1 RBM23	3.68e-04	90	211	6	int:PRR20D
Interaction	CTBP1 interactions	SP1 KLF8 CCND1 ZNF518A FANCA ATXN1 SEC16A GNL3L RBL2 ATXN1L VIRMA YEATS2 DZIP3	3.69e-04	406	211	13	int:CTBP1
Interaction	ZBED10P interactions	ABCF3 ZBED10P THBS1	3.78e-04	14	211	3	int:ZBED10P
Interaction	HPS1 interactions	NEDD1 TASOR AMBRA1	3.78e-04	14	211	3	int:HPS1
Interaction	ZNF236 interactions	ARHGAP24 ZNF236 VIRMA	3.78e-04	14	211	3	int:ZNF236
Interaction	NFIC interactions	NR2C1 KLF8 HIVEP1 ATXN1 ARID3A POU2F1 ATXN1L VIRMA KMT2D	3.83e-04	210	211	9	int:NFIC
Interaction	SMARCA4 interactions	SP1 NR2C1 SRCAP FANCA ATXN1 KPNB1 CAD TENT4B RBL2 CHAF1A TOPBP1 VIRMA NEIL3 ATM	3.84e-04	462	211	14	int:SMARCA4
Interaction	H2BC21 interactions	ARHGAP24 SRCAP NEB TRIP12 SAGE1 PRRC2A CTDSPL2 CHAF1A VIRMA PALB2 PHC2 YEATS2 RIF1 TLN1 RNF20 DZIP3 NEIL3 ZNF292	4.01e-04	696	211	18	int:H2BC21
Interaction	DCTN3 interactions	ABCF3 NEDD1 TRIP12 ATXN1 CLASP1 THUMPD3 THBS1	4.05e-04	128	211	7	int:DCTN3
GeneFamily	Low density lipoprotein receptors	LRP12 LRP6 LRP5	1.15e-04	13	137	3	634
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	FRMPD4 PLEKHH1 TLN1 MYO15A	5.55e-04	50	137	4	1293
GeneFamily	CD molecules\|Type I classical cadherins	CDH4 CDH15	5.62e-04	5	137	2	1185
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	HIVEP1 CRADD TRIO VEZF1 ITGA6 CCND1 LARP4 TRIP12 AHDC1 C2CD5 SLIT2 ATXN1 GLRB SEC24B MTMR3 TASOR VCL SUPT20H CLASP1 SCAF8 TOPBP1 MYO1B SPG11 RIF1 ZNF292	4.35e-08	856	215	25	M4500
Coexpression	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	ACAP1 ABCF3 SRCAP FANCA CACTIN SMG7 XPO5 PRRC2A TCOF1 SZT2 MICALL1 KMT2D TLN1 TNK2 EVI5L	1.47e-07	338	215	15	M17094
Coexpression	FISCHER_DREAM_TARGETS	SP1 AHI1 NEDD1 ZNF518A FANCA RAD54B KPNB1 CCHCR1 CAD TCOF1 CTDSPL2 FAAP24 CHAF1A TOPBP1 POU2F1 PALB2 RFWD3 RIF1 MTHFD1 DZIP3 NEIL3 CNOT1	1.72e-05	969	215	22	M149
Coexpression	GSE11367_CTRL_VS_IL17_TREATED_SMOOTH_MUSCLE_CELL_UP	SLC22A25 NIBAN3 PRRC2A MAT2B PLBD2 TRAM1L1 LRP5 MYO15A	1.82e-05	137	215	8	M460
Coexpression	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	XPO5 PRRC2A DNHD1 SUPT20H TCOF1 SZT2 TOPBP1 TLN1 EIF4G1	2.25e-05	184	215	9	M19988
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	HIVEP1 CRADD TRIO LARP4 TRIP12 C2CD5 GLRB SEC24B TASOR CLASP1 SCAF8 TOPBP1 MYO1B ZNF292	3.39e-05	466	215	14	M13522
Coexpression	GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP	TRPM4 VEZF1 TASOR OPLAH RNF31 ATXN1L PLBD2 KMT2D GRAMD2B	4.33e-05	200	215	9	M331
Coexpression	GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_DN	ITGA6 SH3YL1 ABCD3 PKP1 IGSF9 DSC3 TOPBP1 MUS81 MICALL1	4.33e-05	200	215	9	M7334
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGAP24 TRIO ATXN1 SLC26A3 ANK3 CLASP1 AMBRA1 ZNF407 RANBP17	5.40e-07	198	215	9	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	facs-Tongue-nan-3m-Epithelial-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGA6 LARP4 SMG7 ABCD3 VCL PTBP3 DSC3 ARHGEF12 MTHFD1	5.63e-07	199	215	9	8d50e1ee58710d896c0204937331d9f4dcd38de0
ToppCell	TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3\|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9	TRIO C2CD5 ZNF518A TBCEL KMT2D ATM NFAT5	4.26e-06	135	215	7	ac20133d4a36f48338b45bffb13e842cb66f83ad
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGAP24 ATXN1 SLC26A3 ANK3 CLASP1 AMBRA1 ZNF407 RANBP17	5.17e-06	196	215	8	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	RINT1 REV1 AMT RBL2 ZNF329 SPG11 NFAT5	9.69e-06	153	215	7	553dff9688a1996d8f4ba16e60c683593d781389
ToppCell	Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	RINT1 REV1 AMT RBL2 ZNF329 SPG11 NFAT5	9.69e-06	153	215	7	88ca2d2c2ab19fbee13e18951b993ee05dd30f67
ToppCell	367C-Myeloid-Macrophage-SPP1+_Macrophage_3\|367C / Donor, Lineage, Cell class and subclass (all cells)	DAB2 CA7 CPEB2 TCTE1 PLBD2 CD68 NEIL3	1.19e-05	158	215	7	0559cc032d0b518bb9e55aa3495f5573bd8e87dd
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-Activated_T\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACAP1 TASOR LRP12 RBL2 TMIGD2 LCP1 ATM	1.65e-05	166	215	7	fb2cfbf1d0a0f1950dd24c08ba00ebd64b06ceb4
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ACAP1 NCKAP5 CACTIN CCHCR1 ZNF407 SPG11 EVI5L	1.85e-05	169	215	7	665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	ACAP1 NCKAP5 CACTIN CCHCR1 ZNF407 SPG11 EVI5L	1.85e-05	169	215	7	6614c9851537e4c21b1e45ff0cc3bad07ef9d034
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_2\|368C / Donor, Lineage, Cell class and subclass (all cells)	ZNF236 EMSY FANCA STAMBPL1 GNL3L YEATS2 LRRC37B	2.77e-05	180	215	7	551b8de8d933d11bcd3897aeb2fd033355f958e2
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ITGA6 SH3YL1 ANK3 RBL2 TMIGD2 HABP4 ATM	3.19e-05	184	215	7	5350b58aa9979631228835d11eb45ddf81d08bff
ToppCell	droplet-Lung-LUNG-1m-Myeloid\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DAB2 PTBP3 LRP12 LCP1 LSR PRCP CD68	3.30e-05	185	215	7	53a5218c1e6eb12daccde3d6e02f337e2586d74c
ToppCell	moderate-Lymphoid-B_cell\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ACAP1 GGA2 ARHGAP24 NIBAN3 STAMBPL1 ARID3A ATM	3.41e-05	186	215	7	fd2c4c3e8929ca5d64f6c5064e5f3d3d6ba07b5f
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	SLIT2 STAMBPL1 COL11A1 KIF26B DTNA THBS1 PALLD	3.53e-05	187	215	7	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	GGT5 SLIT2 COL11A1 VASN KIAA1755 CDH4 CDH15	3.65e-05	188	215	7	ed92cddf47defea2f904d36c7ae05ffa323349a9
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PDE4B NCKAP5 PLEKHH1 SHROOM4 C10orf90 CSPG4 KIAA1755	3.65e-05	188	215	7	d9692b6048d9b85524a07a1807bdd4757731c151
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma\|TCGA-Lung / Sample_Type by Project: Shred V9	ABCF3 ITGA6 PKP1 DSC3 MICALL1 YEATS2 CLCA2	3.78e-05	189	215	7	aa4f7d7a5196e5ae481ebc2549de8e3f0ef6e6be
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NR2C1 DAB2 CARD16 SRCAP PALB2 CCDC142 ATM	3.91e-05	190	215	7	63018acb7ad80415e861643162abdc2e55968ee4
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ITGA6 SH3YL1 ANK3 RBL2 TMIGD2 HABP4 ATM	4.04e-05	191	215	7	d9a6f61fcda4f5352488f7f55cb9b57aeacc717f
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_T-T4_naive\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ACAP1 ITGA6 SH3YL1 RBL2 TMIGD2 ATM LRRC15	4.32e-05	193	215	7	2946e8c9328e356cda3dafe7c86e8de462df37da
ToppCell	human_hepatoblastoma-Tumor_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	CRADD ABCD3 ARID3A ZSWIM5 GPAM LRP6 LRP5	4.32e-05	193	215	7	503a979328c68b096680b71359a26f02fafdff35
ToppCell	TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1\|TCGA-Endometrium / Sample_Type by Project: Shred V9	FANCA KPNB1 PTBP3 KIF26B CHAF1A RFWD3 MTHFD1	4.32e-05	193	215	7	c2673d86f7d7b849788036032a93a6d136a70040
ToppCell	droplet-Mammary_Gland-nan-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SERINC2 CCND1 PKP1 ANK3 LSR CLCA2 TNK2	4.32e-05	193	215	7	22ebc3f586eb0aabc5785e468c88d7416c624ff4
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_T-T4_naive-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ACAP1 ITGA6 SH3YL1 RBL2 TMIGD2 ATM LRRC15	4.32e-05	193	215	7	1559d25b3f1c4ea268478ac26ba13f166b96f1dc
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|390C / Donor, Lineage, Cell class and subclass (all cells)	NCKAP5 CACTIN CCHCR1 ZNF407 SPG11 LSR EVI5L	4.46e-05	194	215	7	88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	NCKAP5 CACTIN CCHCR1 ZNF407 SPG11 LSR EVI5L	4.46e-05	194	215	7	a71728202493d4858342ea2756ea281cd0d99a3a
ToppCell	Monocytes-NUPR1+_Monocytes\|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	SF3B4 ARHGAP24 DAB2 IRAK1 ITGA6 TPCN1 CSPG4	4.92e-05	197	215	7	8a058c9d9285acd7cf2fb8e34f7602a86b5d6c89
ToppCell	facs-Tongue-nan-3m-Epithelial\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LARP4 SMG7 ABCD3 VCL PTBP3 DSC3 ARHGEF12	5.08e-05	198	215	7	2f03f8897dd7cce6d8296638e14e11ec16bcf624
ToppCell	distal-mesenchymal-Adventitial_Fibroblast-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ABCA10 SLIT2 VASN CPZ LOXL1 KIAA1755 PALLD	5.08e-05	198	215	7	bfd720e2dae3b6b3dc2bf8b2096c554fd456e756
ToppCell	facs-Tongue-nan-3m\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LARP4 SMG7 ABCD3 VCL PTBP3 DSC3 ARHGEF12	5.08e-05	198	215	7	f2a4057f038ef7225a5b98a7ab068c30dff4eadd
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FANCA RAD54B DSC3 CHAF1A RFWD3 CLCA2 NEIL3	5.08e-05	198	215	7	f088badb90c6c2d916195f5649eda102119c9ac6
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ITGA6 SERINC2 PKP1 IGSF9 DSC3 CLCA2 LOXL1	5.08e-05	198	215	7	22935a8afac54021f68b5f7a5accf51523e2f336
ToppCell	MS-IIF-Lymphocyte-T/NK-NK_CD56bright\|IIF / Disease, condition lineage and cell class	NYNRIN CIBAR2 AMT CLASP1 TMIGD2 RANBP17 TLN1	5.24e-05	199	215	7	9eb2b7d4900b118338590db778a47504559e228d
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	TRIO ATXN1 SLC26A3 ANK3 CLASP1 AMBRA1 ZNF407	5.24e-05	199	215	7	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	AHI1 SLIT2 THBS1 KIAA1755 LRP6 PALLD LRRC15	5.24e-05	199	215	7	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	Sepsis-ICU-SEP-Lymphocyte-T/NK-MAIT\|ICU-SEP / Disease, condition lineage and cell class	SHROOM4 STAMBPL1 LRP12 ARHGEF12 RANBP17 LOXL1 DSEL	5.24e-05	199	215	7	2f10622319c6146dfed8cfe3844180c1e1d56e94
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SRCAP SZT2 ZNF407 LCP1 THBS1 TLN1 CD68	5.24e-05	199	215	7	379bbd9cecf466b902411c54d74bd9885285b1ba
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	PDE4B SPEF2 ITGA6 NCKAP5 CCND1 ARHGEF12 PRCP	5.41e-05	200	215	7	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	Sepsis-Int-URO-Lymphocyte-T/NK-dn_T\|Int-URO / Disease, condition lineage and cell class	NR2C1 ZBED10P SHROOM4 XPO5 CAD GNL3L DZIP3	5.41e-05	200	215	7	020439d9e70fff7246650ab0e9105236688c3ec3
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PDE4B SPEF2 ITGA6 NCKAP5 CASKIN2 ARHGEF12 PRCP	5.41e-05	200	215	7	b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a
ToppCell	mild-unassigned\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ZBED10P CLASP1 TRIM3 PRCP CARF LRRC37B PALLD	5.41e-05	200	215	7	ca0a08bf162c954f037a56aa0cbb8b5d7c6ffec0
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TRIO SPEF2 ITGA6 NCKAP5 ARHGEF12 PRCP TNK2	5.41e-05	200	215	7	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD8+_T_naive\|COVID-19_Mild / Disease, condition lineage and cell class	ACAP1 ITGA6 SH3YL1 RBL2 TMIGD2 ATM DSEL	5.41e-05	200	215	7	7192138e2704c030d70561bcd59259fb3ad82f06
ToppCell	Tracheal-10x5prime-Epithelial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SERINC2 CCND1 SH3YL1 ANK3 DSC3 LSR CLCA2	5.41e-05	200	215	7	efd461c687155c84ef590352207e6fe4ba392a90
ToppCell	Control_saline-Endothelial-Endothelial\|Control_saline / Treatment groups by lineage, cell group, cell type	PDE4B ITGA6 NCKAP5 CCND1 CASKIN2 ARHGEF12 PRCP	5.41e-05	200	215	7	e77eba6172cabf85b8028638ed35299f2f079cd8
ToppCell	Control_saline-Endothelial\|Control_saline / Treatment groups by lineage, cell group, cell type	PDE4B ITGA6 NCKAP5 CCND1 CASKIN2 ARHGEF12 PRCP	5.41e-05	200	215	7	3372c488a39fe812fa94e4f0564594186fea3db5
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	CRADD GNL3L CLASP1 TMIGD2 RANBP17 MTHFD1	6.62e-05	142	215	6	ae495c8dd733f0fde66bddc281606543f21c0d4b
ToppCell	367C-Lymphocytic-CD4_T-cell-Treg_cell_4\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	CRADD CARD16 ABCA10 IGSF9 TBCEL CLCA2	9.64e-05	152	215	6	eb7ff36792c3c54ac88cfe976f84016b70b1a1d7
ToppCell	5'-Adult-Appendix-Hematopoietic-B_cells-Cycling_B_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GGA2 NIBAN3 FANCA LCP1 NEIL3 ATM	1.11e-04	156	215	6	203ef22eb76bd2b829b027c30af0557080f4006c
ToppCell	droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SP1 PDE4B AHI1 RBL2 GRAMD2B ALG13	1.19e-04	158	215	6	1d78578dc1f8ba43dacdccae1082c0b9d749f64d
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	DAB2 VCL COL11A1 DSC3 CD68 CDH4	1.28e-04	160	215	6	dd16ca90feb3ae88b6409d6c278b4765da565514
ToppCell	droplet-Lung-nan-3m-Myeloid-Proliferating_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KLF8 CIBAR2 AMT CHAF1A TOPBP1 ZNF407	1.28e-04	160	215	6	8a7a73b0ee1877fe02d47f745d36ae2858b529e1
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CCND1 SLC23A3 CAD ZNF407 DSEL ZNF292	1.61e-04	167	215	6	3b717d33aaf1ef0869cc4bca8432ba8008875cc5
ToppCell	368C-Lymphocytic-NK_cells-NK_cell_E\|368C / Donor, Lineage, Cell class and subclass (all cells)	ACAP1 VEZF1 MIER3 FANCA AMT TMIGD2	1.72e-04	169	215	6	0d96c0b4fd26fbc0bf44ff7bed2936eebcc55b74
ToppCell	droplet-Thymus-nan-18m-Myeloid-Macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCND1 PKP1 CIBAR2 ANK3 DTNA CD68	1.72e-04	169	215	6	4ac21e8199de4b6917eacadc56fffc6d886ee643
ToppCell	metastatic_Brain-B_lymphocytes-GrB-secreting_B_cells\|metastatic_Brain / Location, Cell class and cell subclass	ARID3A TCOF1 TMIGD2 CHAF1A TOPBP1 CCDC142	1.72e-04	169	215	6	71f6761b9927f352e0ccc221ca373319915f4184
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_C\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	DAB2 ANKS4B GLRB TMIGD2 TLN1 ATM	1.78e-04	170	215	6	81341bf4fe090af70b2091b6b2579ed08d76e22d
ToppCell	droplet-Liver-LIVER-NPC-1m-Lymphocytic-macrophage/monocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AHI1 TPCN1 GGT5 CARMIL2 CTDSPL2 GRAMD2B	1.78e-04	170	215	6	3ad9f950b87ee98f025ab9b4a8ed551e6a9b4764
ToppCell	droplet-Lung-LUNG-1m-Lymphocytic-mature_NK_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACAP1 ATXN1 CA7 PCDHGB7 GRAMD2B TNK2	1.83e-04	171	215	6	f12c2e48637b96557afbc2006a3a23ba21b7951e
ToppCell	droplet-Lung-LUNG-1m-Lymphocytic-Natural_Killer_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACAP1 ATXN1 CA7 PCDHGB7 GRAMD2B TNK2	1.83e-04	171	215	6	12c98dea7370377695c5d22309f78ba03e282a0e
ToppCell	Int-URO-Lymphocyte-T_NK-dnT\|Int-URO / Disease, Lineage and Cell Type	ZBED10P SHROOM4 XPO5 SMIM43 CAD DZIP3	1.89e-04	172	215	6	e70299573da1679d6d286c3a43699cbff76e207d
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VCL ANK3 CHAF1A ZNF329 CCDC142 CLCA2	2.01e-04	174	215	6	3f0a5ce074675d57d479fa069385a1b3071e884e
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-enterocyte_of_epithelium_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANKS4B KBTBD11 IGSF9 SLC26A3 GRAMD2B CEACAM20	2.01e-04	174	215	6	7c52b5d8f1e65e5208c952be341fa155ed0e6e76
ToppCell	367C-Epithelial_cells-Epithelial-I_(AT1)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	NCKAP5 SH3YL1 IGSF9 DSC3 RANBP17 MST1R	2.01e-04	174	215	6	edf839d79ac58921f4e788f3b2cb2ae0d6af4b9e
ToppCell	367C-Epithelial_cells-Epithelial-I_(AT1)\|367C / Donor, Lineage, Cell class and subclass (all cells)	NCKAP5 SH3YL1 IGSF9 DSC3 RANBP17 MST1R	2.01e-04	174	215	6	65539f69100db0b7d90b1b39ee15ab8281f86461
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Enterocyte\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANKS4B KBTBD11 IGSF9 SLC26A3 GRAMD2B CEACAM20	2.01e-04	174	215	6	2fbdb62e269acf4447b171700a615e878dde7f9f
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_A2\|390C / Donor, Lineage, Cell class and subclass (all cells)	TMIGD2 THUMPD3 AMBRA1 PALB2 CARF	2.02e-04	111	215	5	dfbdeadad321392d359e6fb7112b28b043a4b874
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KLF8 LPCAT4 CCND1 PALB2 RNF20 EVI5L	2.08e-04	175	215	6	bb058e714d21a0ec8532eaf3c7dd2faf78016bc0
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_A2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	VASN THUMPD3 AMBRA1 PALB2 CARF GRAMD2B	2.08e-04	175	215	6	334fad1a147de6c007cec5089c02c35cf3220f1b
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_A2\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	ITGA6 VASN THUMPD3 AMBRA1 INTS8 PALB2	2.08e-04	175	215	6	da191dfb8a7f976a632a3a0b923942ab54f5c8c1
ToppCell	droplet-Lung-nan-18m-Myeloid-Ccr7+_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIVEP1 NIBAN3 RAD54B IGSF9 CHAF1A LSR	2.14e-04	176	215	6	24b2e94ee5defcefb64a1f2447a2cc71b015b0fd
ToppCell	droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KLF8 CCND1 AMT CHAF1A TOPBP1 ZNF407	2.14e-04	176	215	6	581045e61cdcdfa85701343d1a7c0a72a36606a7
ToppCell	droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HIVEP1 NIBAN3 RAD54B IGSF9 CHAF1A LSR	2.21e-04	177	215	6	f360f7099570d248531897b96e0de282e58f59e9
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CTTNBP2 NCKAP5 CCND1 LRRC18 FOXD4 LRP5	2.21e-04	177	215	6	e68ad19963a3d8917dfdb81127a41c4fcbe61dd5
ToppCell	myeloid-Dendritic_cell-Plasmacytoid_dendritic_cell\|myeloid / Lineage, cell class and subclass	AHI1 NIBAN3 GLRB STAMBPL1 TMIGD2 LRP5	2.28e-04	178	215	6	f75591988bbbeba073b66329a3437cb9b02f7648
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Epithelial-epithelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GLYAT CIBAR2 SLC26A3 ZSWIM5 MYO15A CEACAM20	2.28e-04	178	215	6	b0baf5667e3301898b3e45e974b8a8530af6a338
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Epithelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GLYAT CIBAR2 SLC26A3 ZSWIM5 MYO15A CEACAM20	2.28e-04	178	215	6	58857bb8c13e0e1c6d9f5c1258f00fff62063d68
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Epithelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GLYAT CIBAR2 SLC26A3 ZSWIM5 MYO15A CEACAM20	2.28e-04	178	215	6	8b7df6ab8709d9ab9dff97677cc4561aec2745bc
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|368C / Donor, Lineage, Cell class and subclass (all cells)	ZNF236 ZBTB24 GPATCH1 CCDC142 TTC31 EVI5L	2.35e-04	179	215	6	10c7d371937d9d93c12c8d3465430ef9e0c2ec81
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LPCAT4 CARD16 CA7 LSR GRAMD2B CD68	2.42e-04	180	215	6	d1beaf1f106c7efaeaf61f29742d0a7310a83916
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Epithelial-Tuft-related\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LPCAT4 CARD16 CA7 LSR GRAMD2B CD68	2.42e-04	180	215	6	156b988b71f6dcf3117c1e5f4625632cb97e54f2
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	POU6F2 CTTNBP2 COL11A1 KIF26B DTNA PALLD	2.49e-04	181	215	6	5f2d3a08577c440c944778d07aa993c6e7873f3d
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ACAP1 PDE4B ARHGAP24 HIVEP1 NIBAN3 ARID3A	2.49e-04	181	215	6	d66838fca0429cad2079cd8d92a5cd33eb0d3522
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	POU6F2 CTTNBP2 COL11A1 KIF26B DTNA PALLD	2.49e-04	181	215	6	c7c5f7d4c397b4613c772413a0a679377efffff3
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FRMPD4 SLIT2 LRRC18 VASN CDH15 LRRC15	2.57e-04	182	215	6	193cb2df3d7ea4cb9a11390b92955e7d9b0a053a
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_T-T8_naive-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ACAP1 ITGA6 SH3YL1 RBL2 TMIGD2 ATM	2.57e-04	182	215	6	3a3ed195c15d33d46a2f395cb93018e4bba28353
ToppCell	facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP24 SLIT2 DTNA GPAM MYO1B LOXL1	2.57e-04	182	215	6	c557de6ccd327c46e0a5423cd9936d78e0abae5f
ToppCell	facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP24 SLIT2 DTNA GPAM MYO1B LOXL1	2.57e-04	182	215	6	dbe4b2557cf19e0682ed446f8397d3a1153642f0
ToppCell	facs-Skin-Telogen-3m-Epithelial-epidermal_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTTNBP2 PKP1 DSC3 C10orf90 LSR CLCA2	2.64e-04	183	215	6	ed1e0b07475f9951728682ed70b85367cf2a744d
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	TRIO TRIP12 RIF1 THBS1 NFAT5 ZNF292	2.64e-04	183	215	6	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DAB2 IGSF9 LRP12 CHAF1A TOPBP1 NEIL3	2.64e-04	183	215	6	e91f00b75d43ee6293fdd4a129b789cd95f8d11a
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ITGA6 ANK3 RBL2 TMIGD2 HABP4 ATM	2.64e-04	183	215	6	f2ef110bf29b1a8276ef216238363e542db262c1
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	DAB2 PLEKHH1 SLIT2 COL11A1 MYO1B	2.69e-04	118	215	5	3f0a304ef9c9e5ba047fc09f4372590eed624328
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3\|TCGA-Lung / Sample_Type by Project: Shred V9	ABCF3 PKP1 LRP12 DSC3 YEATS2 EIF4G1	2.72e-04	184	215	6	ea4ccebe2d54279fcc517e4f0bfa652b91a808bb
ToppCell	Frontal_cortex-Neuronal-Excitatory\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	SERINC2 SMIM43 CA7 BTBD10 RGS14 KASH5	2.72e-04	184	215	6	6e17c8151d6dc543de16d804db956c63c3fda414
ToppCell	normal-na-Lymphocytic_T-T8_naive-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	ACAP1 ITGA6 SH3YL1 RBL2 ATM DSEL	2.72e-04	184	215	6	4a81190b36d197736663e6177d3b76c1cb6282d6
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ITGA6 NYNRIN PKP1 DSC3 CLCA2 LOXL1	2.80e-04	185	215	6	e0172e0ab0f1d7151a3c3c63bb7c84d6bda92035
ToppCell	droplet-Bladder-BLADDER-1m-Hematologic-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACAP1 RAD54B IGSF9 CHAF1A RGS14 NEIL3	2.80e-04	185	215	6	969248b63d4ce335f223528de756bcddffadbd77
ToppCell	pdx-Tumor_cells-T0\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ATXN1 CPEB2 GPAM ANKEF1 KIAA1755 NFAT5	2.80e-04	185	215	6	1d874608aa2062024323512f68889219471b2f00
Computational	Genes upregulated in subsets of cells of a given type within various tumors	TRIO ATXN1 COL11A1 ARHGEF12 RIF1 NFAT5	3.40e-05	50	134	6	GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4
Drug	Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A	GGA2 TRIO DAB2 FANCA SMG7 LRP12 RNF31 RBL2 FAAP24 CHAF1A GOSR1 AMBRA1 THBS1 LRP6	2.97e-09	189	212	14	6649_DN
Drug	colcemid; Up 200; 11.7uM; MCF7; HT_HG-U133A_EA	TRIO ATXN1 PRRC2A VCL DTNA MUS81 MYO1B LCP1 MICALL1 GRAMD2B NFAT5 PALLD	2.36e-07	190	212	12	1103_UP
Drug	Glipizide [29094-61-9]; Down 200; 9uM; MCF7; HT_HG-U133A	SP1 AHDC1 EMSY TPCN1 RAD54B ARID3A DTNA RANBP17 RGS14 ANKEF1 LRP6 ATM	3.49e-07	197	212	12	1508_DN
Drug	3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A	AHI1 DAB2 SMG7 NLE1 TBCEL LRP12 ARID3A SZT2 DTNA ZNF407 RANBP17 NFAT5	3.49e-07	197	212	12	4764_DN
Drug	Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; PC3; HT_HG-U133A	TRPM4 GGA2 TRIO CASKIN2 MTMR3 PRRC2A AMT CLASP1 RBL2 GOSR1 NFAT5 ALG13	3.49e-07	197	212	12	2059_DN
Drug	Caffeic acid [3331-39-5]; Down 200; 22.2uM; MCF7; HT_HG-U133A	NR2C1 TRIO ITGA6 SMG7 KPNB1 PTBP3 ANK3 CHAF1A ZNF329 AMBRA1 MICALL1 LRP6	3.68e-07	198	212	12	5352_DN
Drug	Scopolamine hydrochloride [55-16-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A	TRPM4 SRCAP TPCN1 SMG7 GNL3L DTNA ZNF329 RFWD3 HABP4 TLN1 ATM ZNF292	3.89e-07	199	212	12	4803_DN
Drug	Lycorine hydrochloride [2188-68-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A	SRCAP EMSY RAD54B VCL SCAF8 DTNA ZNF329 AMBRA1 MYO1B RIF1 THBS1	5.30e-07	168	212	11	4365_UP
Drug	Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A	AHI1 ARHGAP24 CCND1 ATXN1 PTBP3 LRP12 GNL3L DTNA MICALL1 ATM NFAT5	1.79e-06	190	212	11	4306_DN
Drug	2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA	NR2C1 AHDC1 CASKIN2 SUPT20H DTNA HABP4 VPS13D LOXL1 TLN1 ATM NFAT5	2.19e-06	194	212	11	1060_UP
Drug	Azapropazone [13539-59-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A	GGA2 ITGA6 NEB EMSY RAD54B PTBP3 ZNF329 THBS1 LRP6 ATM ALG13	2.30e-06	195	212	11	6522_DN
Drug	Nifenazone [2139-47-1]; Down 200; 13uM; PC3; HT_HG-U133A	GGA2 CACTIN GLRB NLE1 PRRC2A KPNB1 SUPT20H CHAF1A ARHGEF12 VPS13D LRP6	2.30e-06	195	212	11	2122_DN
Drug	Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; MCF7; HT_HG-U133A	TRPM4 AHI1 TRIO EMSY CACTIN CASKIN2 ANK3 AMBRA1 DZIP3 TNK2 NFAT5	2.30e-06	195	212	11	2311_DN
Drug	Chicago sky blue 6B [2610-05-1]; Down 200; 4uM; PC3; HT_HG-U133A	TRIO TPCN1 FANCA CASKIN2 KBTBD11 TBC1D30 ARHGEF12 THBS1 VPS13D DZIP3 TNK2	2.30e-06	195	212	11	6626_DN
Drug	Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; MCF7; HT_HG-U133A	SMG7 GNL3L TBC1D30 CHAF1A TRIM3 RFWD3 LRP6 NEIL3 ATM ZNF292 ALG13	2.42e-06	196	212	11	3420_DN
Drug	Pepstatin A [26305-03-3]; Down 200; 5.8uM; MCF7; HT_HG-U133A	TRIO PTBP3 AMT GNL3L SUPT20H ANK3 HABP4 THBS1 VPS13D ATM NFAT5	2.67e-06	198	212	11	3264_DN
Drug	Fluorocurarine chloride [22273-09-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A	AHI1 TRIO ITGA6 CASKIN2 MTMR3 SUPT20H RNF31 GOSR1 MYO1B HABP4 LOXL1	2.80e-06	199	212	11	6219_DN
Drug	Terazosin hydrochloride [63590-64-7]; Down 200; 9.4uM; HL60; HT_HG-U133A	NR2C1 TRIO CCND1 SMG7 MTMR3 NLE1 LRP12 TBC1D30 AMBRA1 TRIM3 MICALL1	2.80e-06	199	212	11	2530_DN
Drug	Lidoflazine [3416-26-0]; Down 200; 8.2uM; PC3; HT_HG-U133A	SP1 SRCAP TPCN1 CACTIN CASKIN2 NLE1 SUPT20H ARID3A ANK3 AMBRA1 ZNF76	2.80e-06	199	212	11	5804_DN
Drug	Furazolidone [67-45-8]; Up 200; 17.8uM; HL60; HT_HG-U133A	POU6F2 MTMR3 SAGE1 VCL HTR1D ANK3 KMT2D LBX1 LOXL1 TNK2 PALLD	2.94e-06	200	212	11	3019_UP
Drug	AH23848 hemicalcium salt hydrate; Up 200; 1uM; PC3; HT_HG-U133A	AHI1 GGA2 TRIO EMSY SMG7 GNL3L SUPT20H FAAP24 RFWD3 ATM	1.12e-05	188	212	10	6885_UP
Drug	Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A	EMSY CACTIN PTBP3 GNL3L DTNA FAAP24 THBS1 DZIP3 ATM NFAT5	1.29e-05	191	212	10	2634_DN
Drug	Chelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A	NR2C1 TRIO NEB ATXN1 VCL ARHGEF12 MICALL1 THBS1 DZIP3 PALLD	1.29e-05	191	212	10	6236_UP
Drug	chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A	SP1 TRIO LPCAT4 GNL3L DTNA ZNF329 TRIM3 LRP6 ATM NFAT5	1.29e-05	191	212	10	5214_DN
Drug	Imipenem [74431-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A	LPCAT4 EMSY TPCN1 CASKIN2 GNL3L DTNA MICALL1 HABP4 ATM NFAT5	1.34e-05	192	212	10	2873_DN
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	TRIO CACTIN CASKIN2 KPNB1 LRP12 LCP1 TRIM3 VPS13D ANKEF1 PALLD	1.41e-05	193	212	10	1022_DN
Drug	Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; PC3; HT_HG-U133A	CASKIN2 NLE1 GNL3L PALB2 TRIM3 TTC31 TLN1 LRP6 ATM CNOT1	1.47e-05	194	212	10	4284_DN
Drug	Dyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A	NR2C1 GGA2 SRCAP TPCN1 CACTIN FAAP24 CHAF1A GOSR1 TRIM3 YEATS2	1.47e-05	194	212	10	7423_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A	LPCAT4 TPCN1 CER1 NLE1 KPNB1 CAD RFX5 TLN1 ATM ALG13	1.54e-05	195	212	10	1561_DN
Drug	Cholecalciferol [67-97-0]; Up 200; 10.4uM; MCF7; HT_HG-U133A	NR2C1 PDE4B ZNF236 SLIT2 LRP12 GNL3L RNF31 VPS13D ATM LRRC15	1.54e-05	195	212	10	3298_UP
Drug	Metaraminol bitartrate [33402-03-8]; Down 200; 8.6uM; MCF7; HT_HG-U133A	AHI1 TRIO SMG7 MTMR3 GNL3L DSC3 DTNA VPS13D ATM NFAT5	1.54e-05	195	212	10	4692_DN
Drug	Luteolin [491-70-3]; Down 200; 14uM; MCF7; HT_HG-U133A	NR2C1 SMG7 CASKIN2 CLASP1 DTNA FAAP24 LCP1 TLN1 GRAMD2B LRP5	1.54e-05	195	212	10	5004_DN
Drug	Cephalothin sodium salt [58-71-9]; Down 200; 9.6uM; HL60; HT_HG-U133A	NR2C1 GGA2 CACTIN DTNA RIF1 VPS13D TNK2 ATM NFAT5 ALG13	1.54e-05	195	212	10	2517_DN
Drug	Sulfamerazine [127-79-7]; Down 200; 15.2uM; PC3; HT_HG-U133A	GGA2 CACTIN ATXN1 TBCEL AMT TBC1D30 SZT2 DTNA AMBRA1 RGS14	1.54e-05	195	212	10	3718_DN
Drug	Crotamiton [483-63-6]; Down 200; 19.6uM; HL60; HT_HG-U133A	ACAP1 LPCAT4 NEB CACTIN RAD54B TBC1D30 ZNF329 MYO1B VPS13D LRP6	1.54e-05	195	212	10	3050_DN
Drug	Mifepristone [84371-65-3]; Down 200; 9.4uM; HL60; HG-U133A	KPNB1 PTBP3 AMT TBC1D30 TCOF1 DTNA CHAF1A MYO1B TRIM3 ALG13	1.61e-05	196	212	10	1569_DN
Drug	chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A	ACAP1 AHI1 GGA2 NEB SLIT2 CACTIN LRP12 DTNA LRP6 ZNF76	1.61e-05	196	212	10	1642_UP
Drug	Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; MCF7; HT_HG-U133A	CACTIN CASKIN2 TBC1D30 GOSR1 TRIM3 THBS1 LRP6 LRP5 TNK2 ATM	1.61e-05	196	212	10	3471_DN
Drug	Pimozide [2062-78-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A	NR2C1 SRCAP SLIT2 CACTIN PTBP3 LRP12 FAAP24 GOSR1 VPS13D LRP5	1.61e-05	196	212	10	6780_DN
Drug	Midecamycin [35457-80-8]; Down 200; 5uM; PC3; HT_HG-U133A	GGA2 TRIO DAB2 MTMR3 PTBP3 TBC1D30 AMBRA1 TRIM3 THBS1 TLN1	1.61e-05	196	212	10	6745_DN
Drug	Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; MCF7; HT_HG-U133A	SP1 NEB EMSY SMG7 LRP12 ARID3A DTNA MICALL1 VPS13D CLCA2	1.68e-05	197	212	10	5436_DN
Drug	Paroxetine maleate [64006-44-6]; Down 200; 1uM; PC3; HT_HG-U133A	AHI1 GGA2 LARP4 LRP12 RBL2 GOSR1 MST1R TNK2 ATM NFAT5	1.68e-05	197	212	10	4556_DN
Drug	Pimozide [2062-78-4]; Down 200; 8.6uM; PC3; HT_HG-U133A	HIVEP1 LPCAT4 AHDC1 CACTIN RINT1 KPNB1 DSC3 THBS1 ANKEF1 LRP6	1.68e-05	197	212	10	7132_DN
Drug	Meclofenamic acid sodium salt monohydrate [6385-02-0]; Up 200; 11.8uM; MCF7; HT_HG-U133A	AHI1 TRIO LPCAT4 TPCN1 LRP12 GOSR1 LSR LRP6 NEIL3 NFAT5	1.68e-05	197	212	10	7038_UP
Drug	Isoxsuprine hydrochloride [579-56-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A	SP1 AHI1 GGA2 SRCAP SMG7 LRP12 TRIM3 RGS14 VPS13D LRP6	1.68e-05	197	212	10	1485_DN
Drug	Lysergol [602-85-7]; Down 200; 15.8uM; PC3; HT_HG-U133A	AHI1 GGA2 SRCAP CASKIN2 NLE1 GNL3L TBC1D30 LSR LRP6 ATM	1.68e-05	197	212	10	6621_DN
Drug	Meglumine [6284-40-8]; Down 200; 20.4uM; MCF7; HT_HG-U133A	GATB SRCAP NEB RINT1 TBC1D30 ZNF329 AMBRA1 YEATS2 ANKEF1 GRAMD2B	1.68e-05	197	212	10	5285_DN
Drug	Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; PC3; HT_HG-U133A	NR2C1 SRCAP GLRB RBL2 GOSR1 MYO1B VPS13D TLN1 ZNF76 NFAT5	1.76e-05	198	212	10	4282_DN
Drug	novobiocin sodium, USP; Down 200; 100uM; MCF7; HG-U133A	TRIO C2CD5 ABCD3 PRRC2A CA7 CHAF1A ARHGEF12 MICALL1 PRCP GRAMD2B	1.76e-05	198	212	10	576_DN
Drug	Metformin hydrochloride [1115-70-4]; Down 200; 24.2uM; MCF7; HT_HG-U133A	PDE4B GGA2 CACTIN SMG7 SUPT20H TBC1D30 CHAF1A LCP1 MICALL1 THBS1	1.76e-05	198	212	10	5487_DN
Drug	Ozagrel hydrochloride [78712-43-3]; Down 200; 15.2uM; MCF7; HT_HG-U133A	TRPM4 NR2C1 CACTIN GNL3L TBC1D30 FAAP24 ZNF329 RFWD3 TLN1 ATM	1.76e-05	198	212	10	5983_DN
Drug	Isocarboxazid [59-63-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A	NEB SMG7 ATXN1 PRRC2A GNL3L DTNA POU2F1 MICALL1 LRP5 ZNF292	1.76e-05	198	212	10	3424_DN
Drug	0225151-0000 [351320-15-5]; Down 200; 10uM; PC3; HT_HG-U133A	SRCAP NEB SMG7 NLE1 ARID3A TBC1D30 GPATCH1 HABP4 THBS1 VPS13D	1.76e-05	198	212	10	6426_DN
Drug	Betulinic acid [472-15-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A	GGA2 TRIO NEB AMT TRIM3 HABP4 THBS1 VPS13D TLN1 LRP6	1.76e-05	198	212	10	3281_DN
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A	SP1 NR2C1 AHI1 PTBP3 ARID3A RNF31 YEATS2 TLN1 NFAT5 ZNF292	1.76e-05	198	212	10	7003_DN
Drug	Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; PC3; HT_HG-U133A	NR2C1 GGA2 TRIO AHDC1 TPCN1 CASKIN2 PTBP3 RNF31 DSC3 LRP6	1.76e-05	198	212	10	7366_DN
Drug	CAY10397; Up 200; 10uM; MCF7; HT_HG-U133A	NEB FANCA CACTIN CASKIN2 RAD54B SUPT20H LCP1 HABP4 RIF1 ZNF76	1.92e-05	200	212	10	7082_UP
Drug	Strophanthidin [66-28-4]; Down 200; 9.8uM; MCF7; HT_HG-U133A	AHI1 GGA2 AHDC1 ATXN1 PRRC2A FAAP24 MICALL1 TLN1 LRP6 NFAT5	1.92e-05	200	212	10	7182_DN
Drug	2-(4-(biphenyl-4-sulfonyl)-piperazin-1-yl)-6,7-dipropoxyquinazolin-4-yl-amine	ITGA6 THBS1 TLN1	2.71e-05	7	212	3	ctd:C525921
Drug	Lycorine hydrochloride [2188-68-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A	TRIO SRCAP SCAF8 DTNA GOSR1 ZNF329 MYO1B RIF1 THBS1	3.21e-05	170	212	9	6051_UP
Drug	Strophantine octahydrate [11018-89-6]; Down 200; 5.4uM; MCF7; HT_HG-U133A	ZBTB24 RAD54B NLE1 TASOR SUPT20H TBC1D30 GOSR1 PALB2 ANKEF1	4.40e-05	177	212	9	5026_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	CCND1 TASOR TBC1D30 SCAF8 GOSR1 MYO1B RBM23 RIF1 THBS1	4.60e-05	178	212	9	1112_DN
Drug	Zuclopenthixol hydrochloride [633-59-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A	AHI1 SRCAP ATXN1 KBTBD11 LRP12 ANK3 GOSR1 ZNF329 MYO1B	5.02e-05	180	212	9	7356_UP
Drug	1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one	DAB2 IRAK1 ITGA6 CASKIN2 VCL COL11A1 VASN THBS1 MTHFD1 TLN1 CD68 LRP5 PALLD	5.11e-05	373	212	13	ctd:C540355
Drug	Digoxigenin [1672-46-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A	ZBTB24 RAD54B TASOR SUPT20H RNF31 TBC1D30 RBL2 GOSR1 PALB2	5.47e-05	182	212	9	5275_DN
Drug	Dilazep dihydrochloride [20153-98-4]; Down 200; 6uM; MCF7; HT_HG-U133A	SP1 ITGA6 CCND1 LRP12 GNL3L FAAP24 HABP4 THBS1 ATM	6.20e-05	185	212	9	4688_DN
Drug	A-T-Y	SLC26A3 MST1R ATM	6.42e-05	9	212	3	CID000445182
Drug	retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA	TRPM4 LPCAT4 ITGA6 CACTIN GOSR1 MUS81 THBS1 GRAMD2B NEIL3	6.47e-05	186	212	9	966_DN
Drug	Ethotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A	AHI1 GLRB LRP12 GNL3L SZT2 RBL2 CHAF1A THBS1 ATM	7.02e-05	188	212	9	4545_DN
Drug	Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A	AHI1 LPCAT4 NEB TPCN1 ANK3 RNF31 DTNA ZNF329 VPS13D	7.93e-05	191	212	9	4969_DN
Drug	Methantheline bromide [53-46-3]; Down 200; 9.6uM; MCF7; HT_HG-U133A	ITGA6 NEB TPCN1 SMG7 FAAP24 DZIP3 LRP6 ATM NFAT5	8.25e-05	192	212	9	6254_DN
Drug	clozapine; Down 200; 10uM; HL60; HT_HG-U133A	SRCAP CACTIN TBC1D30 SZT2 RANBP17 CSPG4 LRP6 MYO15A NFAT5	8.25e-05	192	212	9	6188_DN
Drug	Fenbufen [36330-85-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A	SRCAP SMG7 PTBP3 LRP12 GNL3L SZT2 DTNA FAAP24 ATM	8.25e-05	192	212	9	4743_DN
Drug	Clorgyline hydrochloride [17780-75-5]; Down 200; 13uM; PC3; HT_HG-U133A	GGA2 TRIO NEB SMG7 TBC1D30 FAAP24 ARHGEF12 RFWD3 DZIP3	8.25e-05	192	212	9	6659_DN
Drug	ICI 182,780; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA	CACTIN CASKIN2 PTBP3 SUPT20H DTNA AMBRA1 TLN1 GRAMD2B ATM	8.25e-05	192	212	9	1076_UP
Drug	Resveratrol [501-36-0]; Down 200; 17.6uM; MCF7; HT_HG-U133A	TRIO FANCA PTBP3 GNL3L DTNA THBS1 LRP6 LRP5 NFAT5	8.25e-05	192	212	9	2865_DN
Drug	trifluoperazine dihydrochloride; Up 200; 10uM; HL60; HT_HG-U133A	SP1 ABCF3 SRCAP AMT DTNA MYO1B HABP4 TLN1 DZIP3	8.25e-05	192	212	9	1165_UP
Drug	3-Acetamidocoumarin [779-30-6]; Down 200; 19.6uM; MCF7; HT_HG-U133A	SRCAP SMG7 NLE1 GNL3L DSC3 MYO1B HABP4 ATM NFAT5	8.59e-05	193	212	9	4426_DN
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A	TRPM4 NEB SMG7 PTBP3 GNL3L TRIM3 RFWD3 VPS13D LRP6	8.59e-05	193	212	9	3412_DN
Drug	Ethacrynic acid [58-54-8]; Down 200; 13.2uM; MCF7; HT_HG-U133A	NEB EMSY KPNB1 LRP12 CHAF1A AMBRA1 LCP1 LRP5 NEIL3	8.59e-05	193	212	9	3181_DN
Drug	PHA-00851261E [724719-49-7]; Up 200; 1uM; MCF7; HT_HG-U133A	SP1 GGA2 DAB2 SMG7 MTMR3 RBL2 CHAF1A TRIM3 THBS1	8.59e-05	193	212	9	3857_UP
Drug	Dosulepin hydrochloride [897-15-4]; Down 200; 12uM; MCF7; HT_HG-U133A	SP1 NEB GNL3L DTNA RBL2 FAAP24 RFWD3 LRP6 ATM	8.59e-05	193	212	9	5986_DN
Drug	Diphenidol hydrochloride [3254-89-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A	SP1 GGA2 TRIO EMSY TASOR FAAP24 VPS13D DZIP3 ATM	8.59e-05	193	212	9	7447_DN
Drug	G-6-M	GLYAT ATM	8.63e-05	2	212	2	CID000065891
Drug	Ethamivan [304-84-7]; Down 200; 18uM; PC3; HT_HG-U133A	NR2C1 CASKIN2 GNL3L DSC3 RBL2 ARHGEF12 TNK2 ATM NFAT5	8.93e-05	194	212	9	7260_DN
Drug	Methoxy-8-psoralen [298-81-7]; Up 200; 18.6uM; MCF7; HT_HG-U133A	SRCAP FANCA TBCEL COL11A1 DSC3 MST1R RGS14 VPS13D ZNF76	8.93e-05	194	212	9	3302_UP
Drug	Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; MCF7; HT_HG-U133A	GGA2 ITGA6 SRCAP PTBP3 LRP12 DTNA POU2F1 LRP6 LRP5	8.93e-05	194	212	9	4990_DN
Drug	Felodipine [72509-76-3]; Down 200; 10.4uM; HL60; HT_HG-U133A	GGA2 CACTIN TBC1D30 DTNA MYO1B LRP6 LRP5 ZNF76 ATM	8.93e-05	194	212	9	2433_DN
Drug	Isoetharine mesylate salt [7279-75-6]; Down 200; 12uM; HL60; HT_HG-U133A	SMG7 ANK3 TBC1D30 DTNA MYO1B RANBP17 LRP6 LRP5 ZNF76	8.93e-05	194	212	9	2711_DN
Drug	Clobetasol propionate [25122-46-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A	LPCAT4 SRCAP AHDC1 CASKIN2 AMT SZT2 ZNF407 MST1R RGS14	8.93e-05	194	212	9	6835_UP
Drug	Tiabendazole [148-79-8]; Down 200; 19.8uM; MCF7; HT_HG-U133A	SRCAP CACTIN CASKIN2 LRP12 MICALL1 HABP4 THBS1 VPS13D LRP5	8.93e-05	194	212	9	2840_DN
Drug	Guaifenesin [93-14-1]; Down 200; 20.2uM; MCF7; HT_HG-U133A	NEB CASKIN2 GNL3L RNF31 RANBP17 TLN1 TNK2 ATM NFAT5	8.93e-05	194	212	9	3431_DN
Drug	Methoxamine hydrochloride [61-16-5]; Up 200; 16.2uM; MCF7; HT_HG-U133A	AHI1 HIVEP1 SRCAP CASKIN2 NLE1 TBCEL DSC3 DTNA LCP1	9.29e-05	195	212	9	4972_UP
Drug	Moroxidine hydrochloride [3160-91-6]; Up 200; 19.2uM; PC3; HG-U133A	HIVEP1 DAB2 DSC3 DTNA TOPBP1 AMBRA1 THBS1 VPS13D ALG13	9.29e-05	195	212	9	1944_UP
Drug	Clebopride maleate [84370-95-6]; Up 200; 8.2uM; HL60; HT_HG-U133A	NR2C1 ACAP1 SRCAP AHDC1 MTMR3 ANK3 TRIM3 HABP4 LRP6	9.29e-05	195	212	9	1292_UP
Drug	Scopoletin [92-61-5]; Down 200; 20.8uM; MCF7; HT_HG-U133A	TRPM4 AHI1 EMSY SMG7 CASKIN2 RAD54B RNF31 DSC3 AMBRA1	9.29e-05	195	212	9	6510_DN
Drug	Lumicolchicine gamma [6901-14-0]; Down 200; 10uM; MCF7; HT_HG-U133A	AHI1 SRCAP CACTIN SMG7 KBTBD11 GNL3L MICALL1 ATM NFAT5	9.29e-05	195	212	9	3254_DN
Drug	(+) -Levobunolol hydrochloride [47141-41-3]; Down 200; 12.2uM; PC3; HT_HG-U133A	CASKIN2 AMT GNL3L ARID3A ARHGEF12 THBS1 VPS13D DZIP3 ATM	9.29e-05	195	212	9	6635_DN
Drug	haloperidol; Down 200; 10uM; HL60; HT_HG-U133A	AHI1 SRCAP CACTIN AMT MYO1B THBS1 LRP5 ZNF76 MYO15A	9.29e-05	195	212	9	6163_DN
Drug	Amoxapine [14028-44-5]; Down 200; 12.8uM; PC3; HT_HG-U133A	GGA2 NEB EMSY CACTIN RAD54B TBCEL PTBP3 TBC1D30 LRP6	9.29e-05	195	212	9	6650_DN
Disease	creatinine measurement	KLF8 DAB2 SERINC2 NMRK2 NEB SH3YL1 MTMR3 OPLAH KIF26B SCAF8 FAAP24 LCP1 INTS8 RFWD3 PHC2 RGS14 CSPG4 PCDHGB4 KIAA1755 TNK2 NFAT5	1.05e-05	995	211	21	EFO_0004518
Disease	lung small cell carcinoma (is_implicated_in)	CCND1 XPO5 KMT2D ATM	4.55e-05	28	211	4	DOID:5409 (is_implicated_in)
Disease	Neurodevelopmental Disorders	ILF2 TRIO SRCAP TRIP12 ZNF292 ALG13	5.66e-05	93	211	6	C1535926
Disease	Malignant lymphoma - lymphocytic, intermediate differentiation	CCND1 ATM	1.52e-04	3	211	2	C0555202
Disease	cortical thickness	SP1 CTTNBP2 ABCF3 NCKAP5 SLIT2 SMG7 XPO5 MTMR3 IGSF9 COL11A1 HTR1D CHAF1A ARHGEF12 MUS81 MICALL1 THBS1 VPS13D PCDHGB4 KIAA1755 CD68	1.57e-04	1113	211	20	EFO_0004840
Disease	pancreatic cancer (is_implicated_in)	CCND1 FANCA PALB2 THBS1 ATM PALLD	1.59e-04	112	211	6	DOID:1793 (is_implicated_in)
Disease	multiple myeloma	ILF2 CCND1 SRCAP CCHCR1 RFWD3 DSEL	1.59e-04	112	211	6	EFO_0001378
Disease	peanut allergy measurement	ARHGAP24 ITGA6 EMSY	1.88e-04	16	211	3	EFO_0007017
Disease	Malignant neoplasm of breast	ACAP1 CCND1 EMSY MTMR3 NLE1 PRRC2A COL11A1 DSC3 ZSWIM5 POU2F1 PALB2 MICALL1 RIF1 THBS1 KMT2D CLCA2 LBX1 ANKEF1 ATM	2.79e-04	1074	211	19	C0006142
Disease	bronchopulmonary dysplasia	CARD16 DSC3 TRAM1L1 TNK2	3.01e-04	45	211	4	MONDO_0019091
Disease	lymphocyte count	TCTN3 ACAP1 HIVEP1 SPEF2 MBL2 IRAK1 TRIP12 NIBAN3 GGT5 CCHCR1 HTR1D CARMIL2 PCDHGB7 PCDHGB2 LCP1 MST1R LSR HABP4 MTHFD1 TLN1 PCDHGB4 DZIP3 ATM	3.52e-04	1464	211	23	EFO_0004587
Disease	Adenocarcinoma of prostate	FANCA PALB2 ATM	3.76e-04	20	211	3	C0007112
Disease	brain measurement, neuroimaging measurement	CTTNBP2 ABCF3 NCKAP5 SLIT2 IGSF9 COL11A1 ANK3 KIF26B GPATCH1 THBS1 CARF KIAA1755	6.48e-04	550	211	12	EFO_0004346, EFO_0004464
Disease	Chronic Lymphocytic Leukemia	CCND1 RBL2 TOPBP1 ATM	6.52e-04	55	211	4	C0023434
Disease	mental development measurement	PCDHGB2 DTNA PCDHGB4	7.38e-04	25	211	3	EFO_0008230
Disease	Fanconi Anemia	FANCA PALB2 RFWD3	7.38e-04	25	211	3	C0015625
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	GPAM SPG11 LCP1 CEACAM20	9.64e-04	61	211	4	EFO_0008317, EFO_0008596, EFO_0020946
Disease	pulse pressure measurement	GLYAT KLF8 ARHGAP24 CRADD SRCAP LARP4 AHDC1 ATXN1 STAMBPL1 VCL COL11A1 VASN ARHGEF12 LCP1 INTS8 PHC2 LOXL1 KIAA1755 NFAT5 CNOT1 PALLD	1.07e-03	1392	211	21	EFO_0005763
Disease	remnant cholesterol measurement	ABCA10 NYNRIN KPNB1 LCP1 CEACAM20	1.09e-03	108	211	5	EFO_0010815
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	SEC16A KPNB1 GPAM SPG11 LCP1 NFAT5 CEACAM20	1.14e-03	222	211	7	EFO_0008317, EFO_0020943
Disease	serum IgE measurement	NCKAP5 EMSY SCAF8 TLN1	1.15e-03	64	211	4	EFO_0004579
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	SEC16A KPNB1 GPAM SPG11 LCP1 NFAT5 CEACAM20	1.23e-03	225	211	7	EFO_0008317, EFO_0020947
Disease	Breast Cancer, Familial	RINT1 PALB2 ATM	1.27e-03	30	211	3	C0346153
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	POU6F2 PDE4B HIVEP1 TRIP12 FANCA PRRC2A RANBP17 MST1R NFAT5	1.30e-03	364	211	9	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	free cholesterol measurement	ABCA10 NYNRIN KPNB1 GPAM CEACAM20	1.34e-03	113	211	5	EFO_0008591
Disease	phospholipids:total lipids ratio, intermediate density lipoprotein measurement	GPAM SPG11 LCP1 CEACAM20	1.37e-03	67	211	4	EFO_0008595, EFO_0020946
Disease	cesarean section, anxiety	ATXN1 MAT2B	1.39e-03	8	211	2	EFO_0005230, EFO_0009636
Disease	female breast cancer (is_implicated_in)	PALB2 ATM	1.39e-03	8	211	2	DOID:0050671 (is_implicated_in)
Disease	primary ovarian insufficiency (is_implicated_in)	FANCA XPO5	1.39e-03	8	211	2	DOID:5426 (is_implicated_in)
Disease	childhood trauma measurement, alcohol consumption measurement	ITGA6 PCDHGB7 PCDHGB2 PCDHGB4	1.70e-03	71	211	4	EFO_0007878, EFO_0007979
Disease	primary ovarian insufficiency	DAB2 RBM46	1.77e-03	9	211	2	EFO_0004266
Disease	Pancreatic carcinoma, familial	PALB2 PALLD	1.77e-03	9	211	2	C2931038
Disease	neuroimaging measurement	SP1 CTTNBP2 CRADD MBL2 NCKAP5 LARP4 SLIT2 IGSF9 COL11A1 HTR1D ANK3 SZT2 KIF26B CHAF1A ARHGEF12 THBS1 KIAA1755	1.85e-03	1069	211	17	EFO_0004346
Disease	Nephroblastoma	POU6F2 XPO5 PALB2	2.16e-03	36	211	3	C0027708
Disease	triacylglycerol 52:4 measurement	TASOR LCP1 CNOT1	2.16e-03	36	211	3	EFO_0010416
Disease	Small Lymphocytic Lymphoma	CCND1 ATM	2.21e-03	10	211	2	C0855095
Disease	B-CELL MALIGNANCY, LOW-GRADE	CCND1 ATM	2.21e-03	10	211	2	C1868683
Disease	Fanconi anemia (is_implicated_in)	FANCA RFWD3	2.21e-03	10	211	2	DOID:13636 (is_implicated_in)
Disease	esterified cholesterol measurement	NYNRIN KPNB1 GPAM LCP1 CEACAM20	2.32e-03	128	211	5	EFO_0008589
Disease	serum urea measurement	FANCA SCAF8 RGS14 CSPG4 PCDHGB4 NFAT5	2.88e-03	195	211	6	EFO_0009795
Disease	ulcerative colitis	GLYAT EMSY CCHCR1 LRP12 C1orf141 RGS14 TRAM1L1 CDH15	2.96e-03	335	211	8	EFO_0000729
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	SEC16A KPNB1 GPAM SPG11 LCP1 NFAT5 CEACAM20	3.02e-03	264	211	7	EFO_0008317, EFO_0020944
Disease	free cholesterol measurement, low density lipoprotein cholesterol measurement	NYNRIN KPNB1 GPAM LCP1 CEACAM20	3.11e-03	137	211	5	EFO_0004611, EFO_0008591
Disease	Congenital small ears	SF3B4 TCOF1 KMT2D	3.15e-03	41	211	3	C0152423
Disease	autosomal dominant cerebellar ataxia (implicated_via_orthology)	ATXN1 ATXN1L	3.20e-03	12	211	2	DOID:1441 (implicated_via_orthology)
Disease	cancer (implicated_via_orthology)	ACAP1 ITGA6 TRIP12 PIPSL RBL2 PHC2 ATM	3.28e-03	268	211	7	DOID:162 (implicated_via_orthology)
Disease	smoking behavior	POU6F2 PDE4B CTTNBP2 PRRC2A ZNF407 PHC2 MICALL1 RANBP17	3.30e-03	341	211	8	EFO_0004318
Disease	intermediate density lipoprotein measurement	ABCA10 KPNB1 GPAM CEACAM20	3.56e-03	87	211	4	EFO_0008595
Disease	concentration of large LDL particles measurement	ABCA10 KPNB1 CEACAM20	3.85e-03	44	211	3	EFO_0022160
Disease	cholesterol in medium VLDL measurement	ABCA10 KPNB1 CEACAM20	3.85e-03	44	211	3	EFO_0022225
Disease	grip strength measurement	POU6F2 TRIP12 PRRC2A COL11A1 C10orf90 RANBP17 LOXL1 NFAT5	3.86e-03	350	211	8	EFO_0006941
Disease	nevus count, cutaneous melanoma	CCND1 FANCA ATM CDH15	4.18e-03	91	211	4	EFO_0000389, EFO_0004632
Disease	Fanconi anemia	FANCA PALB2	4.38e-03	14	211	2	cv:C0015625
Disease	triacylglycerol 48:4 measurement	MBL2 ZNF236	4.38e-03	14	211	2	EFO_0010407
Disease	free cholesterol in small VLDL measurement	ABCA10 KPNB1 LCP1	4.64e-03	47	211	3	EFO_0022272
Disease	free cholesterol in very small VLDL measurement	ABCA10 KPNB1 LCP1	4.64e-03	47	211	3	EFO_0022275
Disease	neuroimaging measurement, brain volume measurement	CTTNBP2 CRADD MBL2 NCKAP5 KIF26B GPATCH1 NFAT5	4.67e-03	286	211	7	EFO_0004346, EFO_0006930
Disease	cholesteryl ester measurement, intermediate density lipoprotein measurement	KPNB1 GPAM LCP1 CEACAM20	4.69e-03	94	211	4	EFO_0008595, EFO_0010351
Disease	lipid measurement, intermediate density lipoprotein measurement	KPNB1 GPAM LCP1 CEACAM20	5.06e-03	96	211	4	EFO_0004529, EFO_0008595
Disease	glaucoma	POU6F2 CTTNBP2 COL11A1 ARHGEF12 LOXL1	5.10e-03	154	211	5	MONDO_0005041
Disease	coronary artery calcification	CRADD ATXN1 ANK3 DTNA POU2F1 LCP1 CLCA2 LRP6 CDH4	5.32e-03	450	211	9	EFO_0004723
Disease	triglyceride measurement, alcohol drinking	KPNB1 CTDSPL2 GPAM LCP1	5.64e-03	99	211	4	EFO_0004329, EFO_0004530
Disease	total cholesterol measurement, intermediate density lipoprotein measurement	KPNB1 GPAM LCP1 CEACAM20	5.64e-03	99	211	4	EFO_0004574, EFO_0008595
Disease	coronary thrombosis, GM11992	GPATCH1 PALLD	5.72e-03	16	211	2	EFO_0001124, EFO_1000883
Disease	vitamin C measurement	SLC23A3 RGS14	5.72e-03	16	211	2	EFO_0600003
Disease	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	CCND1 ATM	5.72e-03	16	211	2	C0334634
Disease	corpus callosum volume measurement	CTTNBP2 KIF26B MST1R TLN1	5.84e-03	100	211	4	EFO_0010299
Disease	Adenoid Cystic Carcinoma	CCND1 SRCAP FANCA ATM	5.84e-03	100	211	4	C0010606
Disease	triglyceride measurement, alcohol consumption measurement	KPNB1 CTDSPL2 GPAM LCP1	6.05e-03	101	211	4	EFO_0004530, EFO_0007878
Disease	Weight Gain	ARHGEF12 MYO1B VPS13D PALLD	6.26e-03	102	211	4	C0043094
Disease	non-Hodgkin lymphoma (is_implicated_in)	CCND1 RAD54B	6.45e-03	17	211	2	DOID:0060060 (is_implicated_in)
Disease	Van Buchem disease	COL11A1 LRP5	6.45e-03	17	211	2	C0432272
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	TRIO ZNF292	6.45e-03	17	211	2	DOID:0060307 (is_implicated_in)
Disease	food allergy measurement	ITGA6 EMSY	6.45e-03	17	211	2	EFO_0007016
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	GPAM SPG11 LCP1 CEACAM20	6.47e-03	103	211	4	EFO_0008595, EFO_0020944
Disease	free cholesterol measurement, intermediate density lipoprotein measurement	KPNB1 GPAM LCP1 CEACAM20	6.70e-03	104	211	4	EFO_0008591, EFO_0008595
Disease	bone density	SP1 CTTNBP2 ATXN1 GPATCH1 AMBRA1 CDK5RAP3 LRP5 MYO15A	7.07e-03	388	211	8	EFO_0003923

Protein segments in the cluster

Peptide	Gene	Start	Entry
TPNNLFVGVSNLENA	nan	46	A8MT66
RNSSLPDENNVAQLQ	EVI5L	491	Q96CN4
TNLAAAAADIPQDQL	BTBD10	426	Q9BSF8
NALQENSLADFSLPQ	AKAP2	511	Q9Y2D5
QILAQLPGQAAEASS	ADGRF3	506	Q8IZF5
QGTLQVQLSRANEDP	CIBAR2	251	Q6ZTR7
APVLSNGAAANQAIS	ALG13	861	Q9NP73
NNVTPLDNLLNLSNE	C1orf141	381	Q5JVX7
QTLAANEQAGPINRE	RNF20	461	Q5VTR2
SNQAVQVRPSLNNGL	CTDSPL2	201	Q05D32
EVPQALGRSSLSQQQ	CSPG4	1951	Q6UVK1
AERVQAANALTAPNL	ABCA10	1176	Q8WWZ4
LRNTQLATENPNGDA	AHI1	101	Q8N157
ATNPNLTALDISGNA	CARMIL2	606	Q6F5E8
QLTLNANPLDATQSE	CEACAM20	31	Q6UY09
TLRLAEPQSQGNSQV	ABCF3	71	Q9NUQ8
AASINNSTPLNRAIE	ANKEF1	586	Q9NU02
SNQIRGESSVAQQPL	GATB	36	O75879
DNATPLIQATAANSL	ACAP1	606	Q15027
DPRATAQQLSQALGQ	CCDC142	326	Q17RM4
AQQLSQALGQASLPQ	CCDC142	331	Q17RM4
AVQGLNLRSPNNFLS	CCND1	211	P24385
LRGEAALDQNVPSSN	DNHD1	4596	Q96M86
APSGQTELSQERQNL	AHDC1	821	Q5TGY3
SSTQQDQGLLNRPSA	AMBRA1	356	Q9C0C7
LDQSLSGEAPQTQQA	AMBRA1	516	Q9C0C7
PNSNTPAADLEVQQA	ATXN1	386	P54253
LNSEASPSREAINGQ	CHAF1A	136	Q13111
QDGRQNQSSLSPVLL	CER1	21	O95813
VAGLSAQDISQPLQN	TNK2	446	Q07912
VGLAPQDSQASNILV	ARHGEF12	1341	Q9NZN5
GVAINNTFLPSQNDL	RAD54B	46	Q9Y620
SQRLNFDVSSPNGIL	RANBP17	781	Q9H2T7
AAAQAAALQLNGAVP	RBM23	391	Q86U06
GQISPNSENLIVFAN	RBM46	321	Q8TBY0
IPSFQALGQENSISL	NR2C1	411	P13056
AASGSLLQDLQTDQP	RFWD3	731	Q6PCD5
ESSAPGANNLQVNAL	RFX5	311	P48382
LNASNPEEVLQLAAQ	INTS8	966	Q75QN2
QEGAAPNLNLVSSFL	NIBAN3	611	Q86XR2
QARDQGSPALSANVS	PCDHGB4	531	Q9UN71
TLQARDQGSPALSAN	PCDHGB7	531	Q9Y5F8
DARLQTLANSLDPNG	KASH5	71	Q8N6L0
QAVTGSIQPLSAQAL	RBL2	771	Q08999
TFSAQNASLRDLQAP	CD68	256	P34810
AEQRDFLPLETTNNN	TENT4B	16	Q8NDF8
NQNSLRENPFLTNGI	DAB2	246	P98082
LANNQVRAPGAQSLA	TCTE1	341	Q5JU00
QLNLSGNNLTALPSA	LRRD1	701	A4D1F6
NTLANRFPAVNSLIQ	GOSR1	206	O95249
SQNQSPLRQLDNGVS	LRP12	751	Q9Y561
PDAASQLNVDASGNL	MAT2B	106	Q9NZL9
ARQLQLSDPQTVAGA	LPCAT4	361	Q643R3
IADSIGNNRQNAPLT	NEDD1	571	Q8NHV4
PQAAALNNDSSQNVL	NEIL3	51	Q8TAT5
LQATALQQQPLSAAL	MYO15A	2471	Q9UKN7
GLVSALQATQAQVPA	KIAA1755	646	Q5JYT7
PQESQSALEAAAANG	ATXN1L	256	P0C7T5
GTQLQNQSELRAPTA	KIF26B	636	Q2KJY2
SSQPSLNEAIQNLAA	GLYAT	106	Q6IB77
FVLTSLSQGQNPDRQ	LRP5	1011	O75197
SSSRVLLAGAPQAQQ	LOXL1	71	Q08397
TREANNSLISQNIPG	CARF	51	Q8N187
GPTISAQEAQAQAIL	COL11A1	506	P12107
NDITSQLEINFGNLP	HABP4	351	Q5JVS0
AQNAQSSRAQLSPAA	GPATCH1	466	Q9BRR8
TPFTIQENLNLALNS	LCP1	186	P13796
TLQARDQGSPALSAN	PCDHGB2	531	Q9Y5G2
PGVSNQFLINTNSEL	PDE4B	451	Q07343
PNVSDSLLLQNIFQA	PRCP	316	P42785
SSALQSLQGLQQEPA	KLF8	241	O95600
LNVSNNRLTSNGLPV	LRRC18	101	Q8N456
SLETNNNNVAIPLTG	LRP6	646	O75581
SVATPRNAAENGAIQ	MBL2	161	P11226
QSSSLQEEAPAQLLQ	LRRC37B	276	Q96QE4
PRSSLQQENLVEQAG	MICALL1	321	Q8N3F8
NPSADRNLLDLLSAQ	GGA2	411	Q9UJY4
SQQSAEDLARVPANS	GLRB	41	P48167
NDLQTPLDAAASREQ	ANKS4B	96	Q8N8V4
TAAAENIRLPNAGTQ	ITGA6	1021	P23229
IPDQQLNILNSFTAS	MIER3	381	Q7Z3K6
APSGASAQAAEQLQR	IRAK1	566	P51617
AASQQFLEQSLQPGL	FOXD4	41	Q12950
SQLPNSDALLQQATQ	NFAT5	696	O94916
PGQAQQRLEQTSSSL	CASKIN2	1141	Q8WXE0
ANSQNGEEIVPALTL	DZIP3	91	Q86Y13
ALQGAAQLPANASLA	POU2F1	576	P14859
DPNNEAIRNAVGSLA	PIPSL	831	A2A3N6
QVNNPELGLSRAALQ	PALLD	586	Q8WX93
ASDSINPGNLQLVSE	PALB2	846	Q86YC2
ILNSDTLGNPTNVRN	ARHGAP24	486	Q8N264
PSSTRQAGIIQALQN	ATM	2056	Q13315
AQNLDLNRNFPDLTS	CPZ	316	Q66K79
NVFRTDNNSNTLLPL	CPEB2	196	Q7Z5Q1
DLAQQNLIISNTEAP	DSC3	726	Q14574
PTLLQQAAAQGNVTL	CTTNBP2	711	Q8WZ74
QAQEAASRPLTSQDG	PIK3CD-AS1	146	Q5SR53
NQPAILNLSGSSDDI	FRMPD4	766	Q14CM0
EVSAALQSRQQAAPD	FANCA	1431	O15360
LQSRQQAAPDADLSQ	FANCA	1436	O15360
FPSIQQLSNASIGEL	FAAP24	181	Q9BTP7
LPSQLAEIGAAAQQS	CDK5RAP3	186	Q96JB5
LNSSPSDRQINQLAQ	CRADD	111	P78560
NQDLAPNSAEQASIL	ILF2	61	Q12905
PNLNAINITAADADV	CDH4	626	P55283
LQQQGSPVDATIAAL	GGT5	61	P36269
QSAEGLPQEASNRSL	HTR1D	6	P28221
NASPNELTVNGNTAL	ANK3	786	Q12955
EGAAAQLPSLNNRLS	CCHCR1	451	Q8TD31
IPANLSQNLEAAAAT	EIF4G1	491	Q04637
PSNNVKLAATNALLN	KPNB1	186	Q14974
NNINAATAVALQEPR	LARP4	601	Q71RC2
ALRENALNNLDPNTE	DTNA	61	Q9Y4J8
ALNNLDPNTELNVSR	DTNA	66	Q9Y4J8
SPRAAAAALSQQQSL	CACTIN	126	Q8WUQ7
QGDRQSPINIISSQA	CA7	26	P43166
EPSGLLELNNFTSQQ	EMSY	1276	Q7Z589
SPADRDQIAQQLGLT	LBX1	151	P52954
DNALLALQGPTAAQV	AMT	176	P48728
NTEQAAPSGLRSQVQ	GRAMD2B	386	Q96HH9
ENEGVNSLAAPQRSS	SLC22A25	531	Q6T423
LANINPDAGFAVQLS	SEC24B	951	O95487
DTLAAVAQILQSPQG	SCAF8	186	Q9UPN6
SVQNEAPLQAAALRA	CDH15	341	P55291
DSSNPGLQISLNVNN	DSEL	696	Q8IZU8
LALAQAVQRAAQAPS	MTHFD1	796	P11586
TLGLSAALQAVQDNP	CARD16	86	Q5EG05
QAEANATAISNLLPF	C2CD5	526	Q86YS7
SPASVDNQLNAQLAA	LSR	141	Q86X29
LSNASGAESLAIQPQ	MTMR3	296	Q13615
TPQEAANQLVRVGSN	NYNRIN	276	Q9P2P1
DIQNSLLNRSQESAP	NMRK2	186	Q9NPI5
LRSPNQNVQQAAAGA	PKP1	296	Q13835
TLASDNAQNQGELSP	SZT2	1196	Q5T011
ASVNPQDLQGSLQEL	NLE1	311	Q9NVX2
DLVTLNLGTNNFPSN	SPEF2	1496	Q9C093
AGNPQASTLALQSNI	TCOF1	1281	Q13428
SSLPDNVFSNLRQLQ	LRRC15	306	Q8TF66
RNVTLPDSQAQGSLA	NCKAP5	1206	O14513
PLAFSDSVLNVINQN	RIF1	621	Q5UIP0
STAGVTLQAPQLDIN	OPLAH	336	O14841
TLQAPQLDINTVAAG	OPLAH	341	O14841
LVNNPLASQAAAAAA	POU6F2	296	P78424
ETDPLQQGQALASAL	GNL3L	531	Q9NVN8
VAAELNPDGSAQQQS	GPAM	146	Q9HCL2
NPNRSEVQANLSLFL	SMG7	81	Q92540
APVQLNSGSQSNRNE	SH3YL1	251	Q96HL8
SNPAGIQQALAQLSS	PRRC2A	1471	P48634
QLKNSVANTAGALQP	SMIM43	31	Q4W5P6
ELANQQPSASGSLVQ	SHROOM4	521	Q9ULL8
DRNATTLGLPNNSNN	SLC26A3	151	P40879
SIGQLASLAQRPVAN	SRCAP	1186	Q6ZRS2
NGNITLLPVNSVSAA	SP1	261	P08047
QRATDAVGPQLSLAN	KBTBD11	221	O94819
LNPSQLRSVGSQDAL	SLC23A3	6	Q6PIS1
LPQPQAQNEEAAASS	SOX30	81	O94993
AAVLSLLGSAQVPQQ	SUPT20HL2	726	P0C7V6
LPQLGANENLESQSA	TASOR	1481	Q9UK61
GNLDNRIANPDQLLT	ABCD3	176	P28288
GLSNPNELQAAIDSN	ARID3A	331	Q99856
RNSLQSAVSNIAQAP	CLCA2	871	Q9UQC9
LGDPNSQVRDAAINS	CLASP1	176	Q7Z460
FPLENTELANVGANQ	C10orf90	366	Q96M02
TPGSIALAQAQAQAQ	CNOT1	1011	A5YKK6
QPLQQGDALLASAQS	RNF31	396	Q96EP0
ASLANAQILIPTNQA	SPG11	1056	Q96JI7
AASPAAAQLLNRAQS	PHC2	141	Q8IXK0
TLDNNVVNGSSPAIR	THBS1	241	P07996
NRNPDALTGNVNVLA	TRAM1L1	281	Q8N609
ILSSNSEINQVNGAP	ZSWIM5	306	Q9P217
GQPSALRQVNELANS	nan	66	Q96MF0
QAAQNSLLPLLSSAV	VEZF1	21	Q14119
ALQEASSLSVQQGPN	TMIGD2	16	Q96BF3
GQAQNSAQSPASLVL	SEC16A	1091	O15027
LNDNLISTLPANVFQ	SLITRK1	161	Q96PX8
PQESNSDAGINLIAL	REV1	996	Q9UBZ9
LQSASGQLPATAALN	RINT1	751	Q6NUQ1
INNGQPVADNVLSTA	SAGE1	86	Q9NXZ1
AQPASAEPRQNLLQA	TLN1	626	Q9Y490
DQASLAAVSQQLAPR	TLN1	1676	Q9Y490
NRALTPAATLSAVQN	STAMBPL1	246	Q96FJ0
LSQLGSAENRPEQSL	SUPT20H	701	Q8NEM7
SPQARALASQLQDSL	VCL	566	P18206
AEIAQELLQSNGQPS	ZNF292	1406	O60281
ATEISNLLDNNPRDQ	TTC41P	931	Q6P2S7
QLLSSAFVNLNNIPD	XPO5	871	Q9HAV4
ASAAQASLSQVLPQL	ZBED10P	6	Q96FA7
LSNNQISELAPDAFQ	SLIT2	331	O94813
LRSNNIAELSPGAIN	TBC1D30	601	Q9Y2I9
IPASDTQQLAQEARN	RGS14	106	O43566
TANLQPQTLDTNGFL	ZNF518A	481	Q6AHZ1
GQAQVDSNSSLILRP	IGSF9	461	Q9P2J2
AAQPAQLSSKENALV	PLEKHH1	1231	Q9ULM0
LPNQARAQAALQAVS	PTBP3	141	O95758
PSEAANSLEQAQAAA	CAD	531	P27708
FQPLANLSNLDLTAN	VASN	96	Q6EMK4
NNPLAVNRAANNIAS	THUMPD3	351	Q9BV44
ADQAANLTLLTQQPE	ZBTB24	586	O43167
QRQLSSSAAPAAQQP	TPCN1	791	Q9ULQ1
PNVQISGIDAASINN	ZNF236	1371	Q9UL36
GENAISARSDLNPAN	PLBD2	501	Q8NHP8
VTSLGLAQNPENQSR	ZNF407	366	Q9C0G0
AQQSSSPAADNLREQ	UBE4A	546	Q14139
VILTSQANAPLLAGN	TCTN3	301	Q6NUS6
SQRNTAGAQPQDDSI	TRIP12	16	Q14669
GRLSTQSNSNNIEPA	TRIP12	1051	Q14669
NAVALSASPQLKEAQ	TOPBP1	881	Q92547
VLSAPESLQNLFNNR	VIRMA	1501	Q69YN4
LSSSLNENQRNLPGE	ZNF329	186	Q86UD4
PNLNDLASLDQTAGA	MST1R	991	Q04912
ALNAVGLQVLTANPS	HIVEP1	2516	P15822
DAQPNSGLLQASVIT	SERINC2	261	Q96SA4
AERLLAAQNPLSQAD	SF3B4	191	Q15427
VSNVPQLEFLNLSSN	TBCEL	96	Q5QJ74
AAPSNSLIRNLLDQA	TRPM4	466	Q8TD43
AQQVSLSPEDLQALG	ZNF76	441	P36508
ENQRNFLNALTSPIE	TRIO	2271	O75962
LIPQGAILRATNNAN	YEATS2	776	Q9ULM3
SILPEQGVSALQNNF	TRIM3	66	O75382
VQASPGLLAAALQQS	TTC31	291	Q49AM3
PESSRSNNLIVANLG	VPS13D	2036	Q5THJ4
QSRVLSSPQLAQQGQ	KMT2D	3831	O14686
QLLQSNPVLEAFGNA	MYO1B	141	O43795
SAELASEAGVQQQPL	MUS81	246	Q96NY9
PEINLARANALNVSN	NEB	3956	P20929